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CHAPTER I 
 
INTRODUCTION 
 
Bacterial Pathogens and their Role in Disease. 
Bacterial pathogens pose a serious worldwide health risk. If left untreated, 
infection can be fatal. Unfortunately, antibiotic resistance is increasing, leading to 
the dire need to develop improved, pathogen specific therapeutics. Even 
commensal bacteria, those that typically are not harmful to humans, can lead to 
devastating disease in immunocompromised or unhealthy individuals.  
 Gram-positive Bacteria. Gram-positive bacteria are characterized by their 
thick peptidoglycan wall and lack of outer membrane, which leads to the ability to 
retain crystal violet staining (Fig. 1-1A). There are several well-known gram-
positive pathogens whose infection can lead to disease including the 
Staphylococcal, Streptococcal, Clostridial, and Enterococcal species. For example, 
Streptococcus pneumoniae is the leading cause of bacterial pneumonia and 
currently poses a serious threat due to increasing antibiotic resistance 
(Eurosurveillance editorial, 2015; Gauthier et al., 2007). Another bacterium, 
Clostridium difficile is the most common hospital acquired infection in the United 
States and is considered by the Center for Disease Control and Prevention (CDC) 
to be an urgent threat (Miller et al., 2011). An infection by this bacterium leads to 
severe diarrhea and can be fatal in weakened immune systems.  
Gram-negative Bacteria. Gram negative bacteria are characterized by their 
thin peptidoglycan layer and outer membrane which contains a layer of  
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Figure 1-1: Gram-positive and Gram-negative bacteria. A) Gram-positive 
bacteria are characterized by a thick peptidoglycan layer. B) Gram-negative 
bacteria are characterized by a thin peptidoglycan layer and outer membrane with 
LPS.  
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lipopolysaccharide (LPS) (Fig. 1-1B). LPS can bind to TLRs, which can then 
provoke an immune response, leading to damage of the host cell. Several gram-
negative species have become multidrug resistant (MDR) and some have even 
become carbapenem resistant (carbapenem resistant enterobacteriaceae; CRE). 
Carbapenems are antibiotics typically used to fight against infection of MDR 
bacteria as a final effort to eradicate infection. One of the most common gram-
negative pathogens is Escherichia coli.  E. coli is commensal in healthy 
individuals, but can cause a multitude of different infections, including urinary tract 
infections and diarrhea. Both E. coli and Salmonella enterica are involved in food 
poisoning, and according to the World Health Organization (WHO), these gram-
negative species are responsible for over 120,000 deaths each year (Havelaar et 
al., 2015). Another common environmental pathogen, Pseudomonas aeruginosa, 
is widespread throughout the environment but can be fatal when found in the 
bloodstream of immunocompromised individuals (Aloush et al., 2006; Driscoll et 
al., 2007). A gram-negative bacterium of importance to this work is Helicobacter 
pylori whose colonization in the human stomach can lead to various degrees of 
disease. 
Bacterial Pathogens Use Pili to Colonize the Host. In order for many 
bacteria to be pathogenic they must bind and invade the host cell. One external 
feature of bacteria are pilins and/or fimbriae (smaller forms of pili). Hundreds of 
pilins come together in order to form pili, which are hair-like protrusions that 
extrude from the bacteria. These pili contain adhesins at the tips which interact 
with host cell surface receptors, allowing for binding of bacteria to host (Fig 1-2A) 
(Soto and Hultgren, 1999). Pili are found both in gram-negative and, more 
recently, gram-positive bacteria  
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Figure 1-2: Bacterial attachment and invasion of host cells. A) Bacterial 
adhesion to host cell receptors can be achieved with pili containing adhesins at the 
tips and fimbriae (a smaller yet similar appendage to pili). B) Bacteria utilize 
secretion systems in order to invade host cells by secreting effector proteins. C) 
Bacteria can create microcolonies on the host cell surface leading to biofilm 
formation. 
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(Mandlik et al., 2008; Proft and Baker, 2009; Ton-That and Schneewind, 2004). 
Individual pilins are also prominent components of secretion systems (Fig 1-2B). 
There are different types of pili in gram-negative bacteria, including type I pili, 
pyelonephritis-associated pili (P Pili) and type IV pili (T4P) which are the most 
common type of pili found in several bacterial species. T4P are responsible for a 
multitude of functions including motility, secretion, DNA uptake, and biofilm 
formation (Giltner et al., 2012; O'Toole and Kolter, 1998). T4P also give the 
bacterium a method to attach to the host cell and propel it to the next host cell, a 
novel mechanism that lacks the use of flagella (Giltner et al., 2012; O'Toole and 
Kolter, 1998). Type I pili and P pili are only expressed in the outer membrane and 
utilize the chaperone-usher pathway where they can bind to specific carbohydrate 
receptors on the host cell (Proft and Baker, 2009). Both pili types are found 
throughout Enterobacteriaceae species. For example, uropathogenic E. coli have 
Type I pili responsible for adherence to the bladder and P pili containing factors 
that bind to the kidney epithelium (Wiles et al., 2008). The actions of these pili lead 
to the development of infections including urinary tract infections (Capitani et al., 
2006; Connell et al., 1996; Proft and Baker, 2009; Sauer et al., 2004). The pili of 
Streptococcal species are involved in the development of meningitis, sepsis, and 
pneumonia (Parks et al., 2015) 
Pili can also form structures within secretion systems. Bacterial secretion 
systems allow for the transport of different proteins and molecules for invasion of 
the host cell. (Fig. 1-2B). There are currently eight known secretion systems. One 
of the best characterized T4SS is that of Agrobacterium tumefaciens. The 
component VirB5 of this pilus has been suggested to be localized to the tips of the 
pilus to allow for adhesion to the host cell (Aly and Baron, 2007).  
  6 
 
There are many adhesin factors responsible for host binding. One of the 
best characterized adhesins is located at the distal tip of Type I fimbria of 
uropathogenic E. coli, FimH. FimH binds to mannose receptors of urinary epithelial 
cells in a catch-bond mechanism (Sauer et al., 2016; Thomas et al., 2002; Zhou et 
al., 2001). The binding of FimH to the host urinary epithelial cells is part of the 
virulence of E. coli in the development of urinary tract infections. Another example 
of a bacterial pilus playing a large role in virulence are the T4P of Neisseria 
meningitidis (Berry and Pelicic, 2015). This bacterium is typically located in the 
nasopharynx, however, it can enter the bloodstream where it becomes pathogenic 
leading to the development of septicemia (Pathan et al., 2003). In more severe 
cases, the bacteria can cross the blood brain barrier, leading to the development 
of meningitis (Pathan et al., 2003). It has been determined that two adhesins found 
on the T4P are responsible for bacterial binding to the endothelial cells (Bernard et 
al., 2014), further demonstrating the importance of adhesins as virulence factors. 
Since pili are a major factor in bacterial binding to the host cell through 
different adhesin molecules, they can also play a role in biofilm formation. Biofilms 
are described as microcolonies of bacteria that can exist in the host environment 
(Fig. 1-2C). Due to the ability of bacteria to form these large colonies, they are 
resistant to treatment. A common biofilm is dental plaque, created by commensal 
gram-positive bacteria, such as the Streptococcal and Actinomyecetal species 
(Marsh, 2004).  For example, biofilm formation by Pseudomonas aeruginosa, a 
gram-negative opportunistic pathogen, can lead to pneumonia and other hospital 
acquired infections, that can be fatal if left untreated (Stryjewski and Patel, 2003).  
Pore-Forming Toxins.  
Pore-forming toxins (PFTs) are the most common bacterial toxin and have 
become increasingly important drug targets due to their utilization by many 
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bacteria as virulence factors. Not only do these toxins pose serious health risks 
(i.e. listeriolysin O and alpha hemolysin) but they have also been used as 
biological weapons, as in the case of anthrax toxin (Inglesby et al., 2002; 
Schwartz, 2009). These toxins create pores within membranes, which can alter 
membrane permeability. In order to achieve this, first, the toxin binds as a 
monomer to the membrane via a lipid or protein receptor. Next, the toxin can take 
one of two paths. On the first path, the several monomers will oligomerize on the 
membrane creating a pre-pore state followed by membrane insertion to create the 
pore (Fig. 1-3A). On the second path, the monomers will insert into the membrane 
followed by oligomerization to create a pore (Fig. 1-3B). Once the pore is created, 
the toxin can cause an influx or efflux of ions, small molecules, and/or larger 
molecules such as proteins. PFTs are characterized by the type of pore it creates, 
either alpha helical or beta barrel.   
 Alpha helical pore-forming toxins. There are three major families of 
bacterial a-PFTs: colicins, actinoporins, and cytolysin A (ClyA) (Table 1). These 
toxins have proven to be more difficult to study using structural methods in the 
past twenty years. However, these studies have provided great insight into how 
these toxins come together to create pores and cause host damage. Colicin PFTs 
are found in E. coli and are toxic to other bacterial species (Lakey et al., 1994). 
These toxins are targeted to receptors on the host outer membrane where they 
create a voltage dependent pore within the inner membrane of the host cell (Lakey 
et al., 1991; Ridley et al., 2010). X-ray crystallographic studies have revealed that 
colicin A is comprised of alpha helices that bundle together in three domains that 
take the shape of an ‘umbrella’ (Parker et al., 1992; Parker et al., 1990). The 
channel forming domain contains ten helices that upon contact with the  
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Figure 1-3: Pore formation by PFTs.  PFTs first bind to the host cell receptors as 
soluble monomers. A) PFTs can oligomerize on the surface creating a pre-pore 
intermediate, followed by membrane insertion and pore formation. B) Following 
monomer binding, the monomers can insert in to the membrane and then 
oligomerize to create the pore. Adapted from Peraro, et al (Dal Peraro and van der 
Goot, 2016).  
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Table 1-1: a-PFTs and their respective organisms. Adapted from Peraro, et al 
(Dal Peraro and van der Goot, 2016).  
  
Table 1
PFT Family Organism
Colicin E1 Colicins E. coli
Colicin Ia Colicins E. coli
Colicin A Colicins E. coli
Colicin N Colicins E. coli
Equinatoxin II Actinoporins A. equina
Sticholysin II Actinoporins S. helianthus
Fragaceatoxin C Actinoporins A. fragacea
Cytolysin A ClyA E.coli, S. enterica, S. flexneri
Non-hemolytic tripartite enterotoxin ClyA B. cereus
Hemolysin BL ClyA B. cereus
 1
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membrane, insert to create the pore (Fig. 1-4A) (Ghosh et al., 1994; Wiener et al., 
1997).  
For actinoporins, there are several crystal structures determined of soluble 
monomers. Two recent structural studies by X-ray crystallography and cryo-EM  
with large unilamellar vesicles (LUVs) revealed that fragaceatoxin C (FraC), a 
haemolytic protein toxin of sea anemones, undergoes four major steps to create a 
pore (Morante et al., 2016; Tanaka et al., 2015). First, the soluble monomer binds 
to membrane followed by dimer formation. Then, four dimers come together to 
create a pre-pore intermediate on the membrane surface prior to membrane 
insertion and pore completion (Fig. 1-4B) (Morante et al., 2016; Tanaka et al., 
2015). Previous structural studies of FraC suggested that the toxin is capable of 
forming both octameric and nonameric pores (Mechaly et al., 2011). However, 
both of the recent structural studies strongly suggest that the octameric pore is 
dominant (Tanaka et al., 2015). Interestingly, the crystallographic studies indicated 
that the pore contains openings that may serve to release toxic molecules found in 
sea anemone venom (Tanaka et al., 2015).  
The last family of alpha helical PFTs is the ClyA family. In this family is 
Cytolysin A (also known as hemolysin E or Hlye), and toxins from Shigella 
flexineri, and Salmonella enterica all of which are causes of food poisoning in 
humans. The first crystal structure of ClyA revealed an elongated protein with a 
four helix bundle at the shaft of one end and a characteristic beta-tongue at the 
opposing end proposed to interact with membrane (Wallace et al., 2000). More 
recently, a crystal structure was determined of the ClyA pore in the presence of 
detergent (Mueller et al., 2009) where the authors determined that ClyA transitions 
from a four to a three helix bundle in order to transition to a dodecameric pore 
(Mueller et al., 2009). In the proposed mechanism, the b-tongue interacts with the   
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Figure 1-4: Structure and proposed mechanisms for a-PFTs. A) The structure 
of a colicin A monomer has been determined. To date, there is no structural 
information on the pore-formed state. (PDBID: 1COL) B) Recently, a mechanism 
for pore formation by FraC has been elucidated. Following monomer binding to the 
host, FraC dimerizes on the surface and then creates a pre-pore intermediate 
(structure not known) followed by membrane insertion. (PDBIDs: 3W9P, 4TSL, 
4TSY) C) The mechanism for pore formation by ClyA has been reported where 
after monomer binding, oligomerization and pore formation are likely concomitant. 
(PDBIDs: 1QOY, 2WCD) Adapted from Peraro, et al (Dal Peraro and van der 
Goot, 2016).   
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membrane to enable protomer insertion followed by oligomerization, creating the 
active pore (Fig. 1-4C). Each of these examples represent well characterized and 
proposed mechanisms of pore formation based on structural analysis.  
Beta barrel pore-forming toxins. b-PFTs are more common and found 
throughout both gram-negative and gram-positive bacteria. The largest families of 
b-PFTs are aerolysins, haemolysins, and cholesterol dependent cytolysins (CDCs) 
(Table 1-2). The first crystal structure determined of a b-PFT was that of the 
Aeromonas spp proaerolysin (Parker et al., 1994). Proaerolysin is plays a major 
role in bacterial pathogenesis and can lead to wound infections or gastroenteritis 
(Parker et al., 1994). While several crystal structures have been determined for 
toxin monomers, only recently there have been structural observations of an 
aerolysin pore (Degiacomi et al., 2013). Using a combination of X-ray 
crystallography, cryo-EM and computational modelling, Degiacomi and colleagues 
determined that aerolysin creates a heptameric pore, which had previously been 
suggested using 2D crystallography (Degiacomi et al., 2013; Wilmsen et al., 1992). 
However, in 2016, two structures of aerolysin pores were determined by cryo-EM, 
aerolysin of Aeromonas hydrophilia and lysenin of Eisenia fetida (Bokori-Brown et 
al., 2016; Iacovache et al., 2016). Both structures propose mechanisms in which 
oligomerization occurs on the membrane prior to insertion (Fig. 1-5A).  
 The haemolysin family of b-PFTs are well characterized. The first structure 
determined for haemolysin PFT was in 1996 of the S. aureus a-hemolysin 
heptameric pore (Song et al., 1996). Since then, crystal structures have been 
determined of several haemolysin toxins (De and Olson, 2011; Huyet et al., 2013; 
Olson and Gouaux, 2005; Olson et al., 1999; Savva et al., 2013; Yamashita et al., 
2014; Yamashita et al., 2011). For example, Clostridium perfringens, which is one  
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Table 1-2: b-PFTs and their respective organisms. Adapted from Peraro, et al 
(Dal Peraro and van der Goot, 2016).  
 
  
Table 1
PFT Family Organism
α-haemolysin Haemolysin S. aureus
γ-haemolysin Haemolysin S. aureus
Leukocidins Haemolysin S. aureus
Necrotic enteritis toxin Haemolysin C. perfringens
δ-toxin Haemolysin C. perfringens
V. cholera cytolysin Haemolysin V. cholerae
V. vulnificus haemolysin Haemolysin V. vulnificus
Aerolysin Aerolysin Aeromonas spp.
α-toxin Aerolysin Clostridium spp. 
Hydralysin Aerolysin Cnidaria spp.
ε-toxin Aerolysin C. perfringens
Enterotoxin Aerolysin C. perfringens
Hemolytic lectin Aerolysin L. sulphureus
Kysenin Aerolysin E. fetida
Perfringolysin O CDCs C. perfringens
Suilysin CDCs S. suis
Intermedilysin CDCs S. intermedius
Listeriolysin O CDCs S. monocytogenes
Lectinolysin O CDCs S. mitis
Anthrolysin O CDCs B. anthracis
Streptolysin O CDCs P. luminescens
 1
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Figure 1-5: Structure and proposed mechanisms for b-PFTs. A) The 
mechanism for pore formation by aerolysin has been reported where after 
monomer binding, oligomerization occurs on the surface creating a pre-pore 
intermediate. A structure of a post pre-pore (or quasipore) state has been 
determined followed by pore formation. (PDBIDs: 1PRE, 5JZH, 5JZT, 5JZW) B) 
The NetB monomer crystal structure has been determined. Following monomer 
binding to the host is membrane insertion. No intermediate structure has been 
determined. (PDBIDs: 4H56, 41ON)  C) Pneumolysin binds as a monomer then 
creates a pre-pore intermediate followed by membrane insertion and pore 
formation. (PDBID: 5AOD; EMDBID: 1106, 1107, 1108) Adapted from Peraro, et al 
(Dal Peraro and van der Goot, 2016).   
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of the top five leading causes of food borne illnesses in the United States, 
expresses two b-PFTs whose high-resolution structures have been determined 
(Huyet et al., 2013; Savva et al., 2013). The heptameric pore crystal structure of 
Necrotic enteritis toxin B-like, or NetB (responsible for necrotic enteritis in poultry), 
was determined and revealed a similar domain architecture to a-hemolysin as well 
as an overall similar 3D structure (Fig. 1-5B) (Savva et al., 2013). 
The CDC family of b-PFTs is more prevalent in gram-positive bacteria. 
These PFTs are thiol activated and use cholesterol as the receptor on host cells. 
Examples include listeriolysin O (LLO; from Listeria monocytogenes, a leading 
cause of listeriosis), perfringolysin O (PFO; from Clostridium perfringens, a leading 
cause of food borne illness), pneumolysin (of Streptococcus pneumoniae, which 
causes pneumonia) and streptolysin O (SLO; from Streptococcus pyogenes, a 
cause of skin infection). Although each of these toxins leads to a different disease, 
their mode of action is similar where domain 4 of an inactive monomer binds to a 
cholesterol-rich membrane, followed by oligomerization of 30-50 monomers, with a 
final step of membrane insertion creating the active pore, inducing lysis of the 
target cell (Tweten, 2005). While there have been several crystal structures 
determined of the monomeric form of CDCs, high resolution structural information 
has been difficult to obtain of these toxins in the pore-formed state. One of the best 
characterized of the CDCs is PFO. Initial x-ray crystallographic data determined 
that PFO is composed predominantly of b-sheets comprised of 4 domains 
(Rossjohn et al., 1997). Domain 4 was postulated to be responsible for host cell 
binding. Subsequently, structures determined of CDCs have verified this role for 
domain 4 and revealed that domain 3 spans the membrane (Feil et al., 2014; 
Koster et al., 2014; Lawrence et al., 2015; Marshall et al., 2015). There have been 
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low resolution cryo-EM studies of pre-pore and pore-formed CDCs. For example, 
cryo-EM analysis of pneumolysin revealed both a pre-pore and pore state where 
the pore diameter measured at ~300 Å (Fig. 1-5C) (Tilley et al., 2005).  
Given the role that each of these PFTs plays in virulence and disease 
progression, continuation of structural studies is imperative. With the 
improvements in structural techniques, technology and the advancements made 
with cryo-EM, hopefully the future will bring more structures of the pore-formed 
states of toxins that have eluded scientific research. 
Helicobacter pylori 
 Helicobacter pylori is a gram-negative spiral shaped bacterium that infects 
and colonizes the human stomach. Typically, the acidic pH of the stomach makes 
it an inhospitable environment for bacterial growth and colonization. However, H. 
pylori has two major characteristics that allow the bacteria to colonize. First, H. 
pylori synthesizes the enzyme urease, which hydrolyzes urea in order to generate 
ammonia (NH3) and carbamate, followed by further decomposition into one more 
NH3 ion and carbonic acid.  The release of ammonia creates a buffer for the 
bacteria to temporarily survive in the acidic environment of the stomach lumen 
(Atherton, 2006; Mobley, 1996; Montecucco and Rappuoli, 2001). Second, the 
bacteria are capable of colonizing the human gastric mucus layer, a feat that no 
other bacteria can accomplish. The urease also alters the viscosity of the gastric 
mucus. With this altered viscosity as a result of urease activity, H. pylori makes 
use of its flagella as well as its spiral shape to travel through the mucus layer in a  
‘corkscrew’-like mechanism toward the neutral pH of the stomach mucosa (Fig. 1-
6) (Atherton, 2006; Salama et al., 2013).  
Disease Progression and Epidemiology. H. pylori is thought to be 
transmitted by contaminated food and water and orally through families, most likely  
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Figure 1-6: H. pylori movement through mucosal layer to reach gastric 
epithelium. H. pylori utilizes its spiral shape and flagella in order to traverse the 
thick mucosal layer. In order to combat the acidity of the environment, the bacteria 
produce urease which catalyzes the conversion of urea to ammonia and carbon 
dioxide.   
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during childhood (Brown, 2000; Bui et al., 2016). Its persistent colonization in the 
stomach leads to the development of chronic gastritis, and in some cases peptic 
ulcer disease, mucosa-associated lymphoid tissue (MALT) lymphoma or gastric 
adenocarcinoma (Atherton and Blaser, 2009; Cover and Blaser, 2009; Marshall et 
al., 1984; Suerbaum and Michetti, 2002; Uemura et al., 2001). Due to the 
involvement of H. pylori in the development of these cancers, the World Health 
Organization classified the bacteria as a type I carcinogen in 1994 (Anonymous, 
1994). Gastric cancer is the second leading cause of cancer-related deaths in the 
world, and it is more prevalent in developing countries, where infection can be as 
high as 90% of the population (Leja et al., 2016). Currently, the bacteria infect 
approximately 50% of the world’s population (Amieva and El-Omar, 2008; 
Atherton, 2006; Nomura et al., 1991; Parsonnet et al., 1991a; Parsonnet et al., 
1991b; Suerbaum and Michetti, 2002). 
Adhesin Molecules. There are several adhesin proteins of H. pylori that aid 
in bacterial to attachment to host cells and each adhesin serves a different role. 
The best characterized adhesins are blood-antigen binding protein (BabA) and 
sialic acid binding protein (SabA). Recent x-ray crystallographic analysis has 
determined the binding site of BabA to lewis B antigens, a great step in 
understanding how the bacteria adheres to host gastric epithelium through blood 
antigens (Hage et al., 2015). BabA exhibits striking similarities in overall 3D 
structure when compared to SabA. Structural and functional analysis will be 
required to fully understand how these adhesins function in different strains of H. 
pylori and their role in the development of disease.  
Increasing Antibiotic Resistance. Traditionally a triple therapy consisting of 
a proton pump inhibitor (PPI) and two antibiotics (such as clarithromycin, 
metronidazole, or amoxicillin) has been given to patients in order to eradicate the 
  19 
 
infection. However, there has been increasing resistance to clarithromycin and 
metronidazole, leading to necessity for different therapeutics, such as the use of 
bismuth (Urgesi et al., 2012). While other therapies are becoming more widely 
utilized, the antibiotic resistance threat poses a need for development of a more 
specific drug target. Structural studies of the virulence factors of H. pylori will grow 
increasing useful toward this goal.  
Virulence Factors. H. pylori secretes two major virulence factors – 
cytotoxin-associated antigen A (CagA) and vacuolating cytotoxin A (VacA; detailed 
in the next section). VacA is secreted by nearly all strains of H. pylori; however, 
CagA is not found in all strains of the bacteria but its presence is associated with a 
higher risk of developing H. pylori associated diseases (Blaser et al., 1995; 
Covacci et al., 1993; Crabtree et al., 1991; Gwack et al., 2006). It has been 
suggested that patients with gastric cancer are two times more likely to have a 
cagA positive strain of H. pylori than a cagA negative strain (Blaser et al., 1995; 
Gwack et al., 2006).  
The cag pathogenicity island is 40kb segment that encodes for cagA and 
components for the type 4 secretion system (T4SS) of H. pylori (Censini et al., 
1996). CagA is the last encoded gene and is an effector protein that is injected into 
the host cell by a T4SS and is the only known effector protein of the bacteria 
(Akopyants et al., 1998; Censini et al., 1996). Once inside the host cell, CagA can 
elicit several cellular effects, both in its phosphorylated and unphosphorylated 
state. If left unphosphorylated, for example, CagA can cause disruption of tight 
junctions and adherens junctions, cell proliferation and differentiation, cell 
scattering, and inflammatory response induction (Amieva et al., 2003; Bagnoli et 
al., 2005; Brandt et al., 2005; Chang et al., 2006; Franco et al., 2005; Lee et al., 
2010; Mimuro et al., 2002; Murata-Kamiya et al., 2007; Oliveira et al., 2009). CagA 
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is phosphorylated at a Glu-Pro-Ile-Tyr-Ala (EPIYA) motif located at its C-terminus 
and this phosphorylation event can result in activation of signaling pathways, 
leading to changes in cell motility and shape (Brandt et al., 2007; Higashi et al., 
2002; Suzuki et al., 2005; Tammer et al., 2007). Recently, the core membrane 
spanning components of the T4SS of H. pylori were visualized using negative stain 
single particle EM (Frick-Cheng et al., 2016). The data revealed that the core 
complex is a ring-like structure with 14 spoke-like densities, suggesting a 14-fold 
symmetry, connected to an inner ring. The side view of the complex revealed a 
stalk-like structure representing the membrane spanning region. Using mutational 
analysis with negative stain electron microscopy, the authors were able to localize 
the different components of the complex. Further high resolution structural analysis 
will be required to better understand the mechanism of CagA secretion and the 
structure of the corresponding secretion system. 
Vacuolating Cytotoxin A   
Vacuolating cytotoxin A, VacA, is a pore-forming exotoxin secreted by H. 
pylori. Known for its ability to induce the formation of large vacuoles when applied  
to cells, the vacA gene encodes a 139kDa preprotoxin that is secreted by the 
autotransporter pathway (type Va secretion pathway) (Fig. 1-7A). The VacA 
preprotoxin contains a signal sequence, passenger domain, and an 
autotransporter domain (Fig. 1-7B). In this pathway, the C-terminus inserts into the 
membrane forming a b-barrel pore. Then a linker region within the autotransporter 
domain moves through the pore followed by folding of the passenger domain once 
it has passed through the pore. The final step is proteolysis yielding the mature 
toxin. Once VacA has undergone cleavage at the N- and C-terminus, an 88kDa 
mature toxin emerges (Fig 1-7C). The mature toxin contains two distinct domains, 
  21 
 
an N-terminal p33 domain and a C-terminal p55 domain (de Bernard et al., 1998; 
Torres et al., 2004).  
There are currently three known polymorphic regions within VacA that are 
associated with different degrees of virulence of the bacteria (Fig. 1-7C). The 
signal region, or s region, is located at the N-terminus of the mature toxin. Noted 
s1 and s2, the differences between them are the result of differential cleavage of 
the N-terminus after secretion (McClain et al., 2001b). The s2 form contains a 
twelve amino acid hydrophilic extension and is associated with a lower risk of 
disease and inability to induce vacuolation within cells (Letley and Atherton, 2000; 
McClain et al., 2001b). The intermediate region, or i region, is located at the C-
terminus of the p33 domain, near the linkage between both domains, and are 
designated i1, i2, and i3 (Rhead et al., 2007). This region has been reported to be 
involved in the ability of VacA to vacuolate cells as well as the ability of VacA to 
bind different cell types(Gonzalez-Rivera et al., 2012; Rhead et al., 2007). It has 
been suggested that this region is the best marker for the development of disease 
(Rhead et al., 2007). The middle region, or m region, is located within the center of 
the p55 domain and the major sequence difference between m1 and m2 is an 
additional 23 amino acids between residues G475 and I476 of m1 (Atherton et al., 
1995; Cover et al., 1994). The polymorphism in this region is associated 
differences in cell tropism (Pagliaccia et al., 1998). VacA s1/i1/m1 is the most 
common allele and vacuolates cells efficiently and is associated with a higher risk 
of disease while VacA s2/i2/m2 is incapable of vacuolating cells efficiently and is 
associated with a lower risk of disease (Cover and Blanke, 2005).  
 VacA domain architecture. As previously mentioned, VacA is composed of 
two domains, p33 and p55 (Fig. 1-7C). Each domain is responsible for different 
VacA effects, but both domains are required for cell vacuolation and host cell  
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Figure 1-7: VacA secretion and polymorphic regions related to virulence. A) 
VacA is secreted via the type Va secretion system (or autotransporter pathway) 
where first the autotransporter domain creates a b-barrel pore through which the 
signal peptide extends. Then the passenger domain is threaded through and 
properly folded once in the outer membrane. The signal peptide is then cleaved. B) 
The VacA preprotoxin is composed of a signal sequence, passenger domain and 
autotransporter domain. C) VacA contains three regions of polymorphism, the 
signal (s) region, intermediate (i) region, and the middle (m) region. Differences in 
these regions are related to differences in virulence. Adapted from Desvaux, et. al. 
(Desvaux et al., 2004). 
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binding (Cover and Blanke, 2005; Domanska et al., 2010; El-Bez et al., 2005; 
Gonzalez-Rivera et al., 2010; McClain et al., 2003; Torres et al., 2005). The p33 
domain is also responsible for VacA pore formation (McClain et al., 2003). It 
contains a stretch of 32 uncharged residues that are responsible for insertion into 
membrane (Cover and Blanke, 2005; Nguyen et al., 2001). Within these 32 
residues are three tandem repeats of a known membrane insertion motif, GXXXG, 
which were first discovered in human glycophorin A (GpA) as dimerization motifs 
(Furthmayr and Marchesi, 1976; Lemmon et al., 1992; McClain et al., 2003; Russ 
and Engelman, 2000; Teese and Langosch, 2015).  In fact, deletion of these motifs 
abolishes the ability of VacA to create an active pore and induce vacuolation 
(McClain et al., 2001a; McClain et al., 2003). Studies have shown using planar 
lipid bilayers in combination with electrophysiology that VacA forms an anionic 
channel within the membrane, with a preference for channeling chloride ions 
(Czajkowsky et al., 1999; Czajkowsky et al., 2005; Iwamoto et al., 1999; Szabo et 
al., 1999; Tombola et al., 1999a; Tombola et al., 1999b).  
 The p55 domain is responsible for VacA binding to receptors on host cells. 
There have been numerous reported receptors for VacA. VacA has been shown to 
be targeted to lipid raft and a major component of lipid rafts, the sphingolipid 
sphingomyelin, has recently been shown to be a VacA receptor (Geisse et al., 
2004; Gupta et al., 2008; Kuo and Wang, 2003; Nakayama et al., 2006; Patel et 
al., 2002; Schraw et al., 2002). Other receptors reported for VacA include receptor 
protein tyrosine phosphatases (RPTP) a and b, low density lipoprotein receptor-
related protein-1 (LRP-1), epidermal growth factor receptor (EGFR), heparan 
sulfate, CD18, glycosphingolipids, and phospholipids (Foegeding et al., 2016; Kuo 
and Wang, 2003; Ricci et al., 2000; Seto et al., 1998; Utt et al., 2001; Yahiro et al., 
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1999; Yahiro et al., 2012; Yahiro et al., 2003). This wide range of receptors for 
VacA lends to the toxin’s ability to trigger a multitude of cellular effects. 
 Cellular Effects of VacA. VacA is internalized into cells via clathrin 
independent, actin dependent and Cdc42 dependent pinocytosis (Gauthier et al., 
2007; Gauthier et al., 2005; Gauthier et al., 2004; Sewald et al., 2011). Once 
internalized, it is known that VacA is found in glycosylphosphatidyl inositol 
anchored protein (GPI-AP) enriched early endosomal compartments (GEECs) 
(Gauthier et al., 2007). Followed by detection in early endosomes, VacA is found 
late endosomes where vacuolation occurs (Gauthier et al., 2007; Sewald et al., 
2011).  
As previously mentioned, VacA is named for its ability to induce large 
vacuoles when applied to cells. Vacuolation is the result of anion channel  
formation in endosomes, allowing for the influx of chloride ions upon activation of 
V-type ATPases, to which VacA has been shown to colocalize (Genisset et al., 
2007; Morbiato et al., 2001). This leads to the accumulation of weak bases, 
leading to osmotic swelling (Fig. 1-8A). The Rab7 GTPase is required for this late 
endosomal swelling (Papini et al., 1998a). A mutant lacking the membrane 
spanning GXXXG motifs, VacA D6-27, not only lacks the ability to vacuolate cells 
but also exhibits a dominant negative effect when mixed with VacA s1/i1/m1 
(Chambers et al., 2013; Vinion-Dubiel et al., 1999). 
 VacA intoxication also leads to alterations in mitochondrial function 
resulting in cell death. Intriguingly, it has been demonstrated that VacA p33 
colocalizes with mitochondria by targeting the inner mitochondrial membrane  
 (IMM), leading to apoptosis (Fig. 1-8B) (Domanska et al., 2010; Galmiche et al., 
2000). Later studies reported that purified VacA interacts with mitochondria leading 
to the depolarization of mitochondrial membrane potential, followed by the release  
  25 
 
 
 
Figure 1-8: VacA causes multiple cellular effects. When VacA is applied to 
cells, it induces different cellular effects. These effects include vacuolation (A), 
mitochondrial dysfunction (B) and membrane permeability, proinflammatory 
signaling (C), and T cell inhibition (D). Adapted from Palframan, et al. (Palframan 
et al., 2012).  
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of cytochrome c into the cytosol, and thus, cell death (Calore et al., 2010a; Gebert 
et al., 2003; Jain et al., 2011; Nakayama et al., 2004; Radin et al., 2011; Sewald et 
al., 2008b; Sundrud et al., 2004; Terebiznik et al., 2009; Willhite and Blanke, 2004; 
Willhite et al., 2003; Yamasaki et al., 2006). In contrast to the idea that VacA 
directly interacts with mitochondria, Yamasaki, et. al. reported that VacA continues 
inducing vacuolation and does not interact directly with mitochondria or induce 
cytochrome c release; however, VacA does increase activity of pro-apoptotic 
factors Bax and Bak (Yamasaki et al., 2006). Therefore, the mechanism of action 
that VacA takes in order to induce apoptosis is not well understood. An 
endosomal-mitochondrial juxtaposition has been proposed; however, this has not 
been previously observed inside the cell and no other evidence of this fusion exists 
(Calore et al., 2010b). 
 Not only does VacA induce membrane depolarization in mitochondria, but 
the toxin also alters membrane permeability in epithelial cells, allowing for the 
efflux of molecules other than chloride ions (Amieva et al., 2003; Debellis et al., 
2001; Papini et al., 1998a; Pelicic et al., 1999; Tombola et al., 2001). This could 
potentially be beneficial for the bacteria in order to continue colonization within the 
stomach. VacA can also bind and induce proinflammatory signalling (Fig. 1-8C) 
(Palframan et al., 2012). 
 H. pylori vacA+ bacteria as well as purified VacA application to gastric 
epithelial cells (AGS cells) has been shown to induce autophagy 
(Greenfield and Jones, 2013; Raju et al., 2012; Terebiznik et al., 2009; Yahiro et 
al., 2012). One study determined that VacA induced autophagy is dependent on 
channel formation by VacA, as mutants unable to oligomerize and the s2/m2 form 
of VacA was unable to induce autophagy (Terebiznik et al., 2009). 
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 Previous studies have shown that the interaction of VacA with T 
lymphocytes (T cells) hinders the IL-2 signaling pathway (Fig. 1-8D) 
(Boncristiano et al., 2003; Gebert et al., 2003; Sundrud et al., 2004).  More 
recently, a T cell receptor for m1-VacA has been identified, CD18, which is an 
integrin subunit found on T cells (Sewald et al., 2008b). The interaction between 
these two proteins suggests a potential immunomodulatory role for VacA.   
Overall Structure of VacA. Although VacA is secreted as an 88kDa 
monomer, it is capable of forming large oligomeric complexes at neutral pH, 
including single-layer hexamers and heptamers and double-layered dodecamers 
and tetradecamers (Adrian et al., 2002; Chambers et al., 2013; Lanzavecchia et 
al., 1998; Lupetti et al., 1996). Upon acid-activation of the toxin, which is required 
for cellular internalization, the oligomers are dissociated into monomers (Cover et 
al., 1997; McClain et al., 2000; Yahiro et al., 1999). Due to the heterogeneity of 
VacA, structural determination efforts have been hindered. In 2004, a crystal 
structure of the majority of the p55 domain was determined to 2.4 Å resolution 
(Fig. 1-9A) (Gangwer et al., 2007). The crystal structure revealed that the p55 
domain, residues 355-811, consists of a right handed b-helix with a globular 
domain at the C-terminus. Unfortunately, efforts to crystallize the full length 
monomer has been difficult due to the flexibility of the p33 domain. An important 
result of the study was that the authors were able to place the crystal structure into 
a previously determined oligomer structure and demonstrate that the p55 domain 
is localized to the arms of the oligomer (Gangwer et al., 2007; Ivie et al., 2010). 
Gonzalez-Rivera reported a 4.5 Å crystal structure of a non-oligomerizing form of 
VacA, D346-347, a mutant that contains a two amino acid deletion at the N-
terminus of the p55 domain, near the junction of p33 and p55 (Fig. 1-9B) 
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(Gonzalez-Rivera et al., 2016). Negative stain analysis shows that this mutant at 
neutral pH resembles acid-activated monomeric VacA (Chambers et al., 2013; 
Gonzalez-Rivera et al., 2016; Pyburn et al., 2016). While the authors were able to 
determine that the b-helix continued into the p33 domain, the N-terminus remained 
unresolved leading to the hypothesis that the pore-forming region of p33 is 
disordered until in contact with membrane. 
 There have been multiple deep etch microscopy studies performed two 
decades ago that gave the first glimpses into VacA oligomer structure. A first look 
at VacA oligomers using deep etch transmission electron microscopy (TEM), 
revealed that VacA forms ‘flower-like’ structures mainly consisting of hexamers 
and heptamers (Adrian et al., 2002; Cover et al., 1997; Lanzavecchia et al., 1998; 
Lupetti et al., 1996). Cover, et. al. showed that VacA oligomers also extend to 12-
mers and that acid dissociated VacA can re-anneal to form the large oligomeric 
complexes when the pH is raised back to neutral (Cover et al., 1997). Later studies 
using cryo-negative staining revealed that VacA not only creates hexamers and 
heptamers, but also octamers, nonamers, as well as double-layered oligomers 
(Fig. 1-9C) (El-Bez et al., 2005). Computational modeling was then performed to 
generate ~19 Å structures of the oligomers, the highest resolution of an oligomer 
at the time. One major observation of this study was that in order to form the 
double-layered oligomers, two single-layers undergo different degrees of rotation 
in relation to one another, leading to different forms of double-layers (El-Bez et al., 
2005). Unfortunately, despite the efforts and improved technology, the central 
region was unresolvable, continuing the lack of information regarding the p33 
pore-forming domain. 
 VacA membrane interactions. The transition of VacA from a secreted 
soluble protein to a membrane inserted protein has been difficult to study  
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Figure 1-9: Known structural information of VacA. A) Crystal structure of p55 
revealed a b-helix with a globular domain at the C-terminus (PDBID: 2QV3). B) 
Crystal structure of VacA D346-347 showed that the b-helix extends into the p33 
domain (Gonzalez-Rivera et al., 2016). C) Previously reported cryo-negative EM 
structures determined using computational methods (El-Bez et al., 2005).  
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structurally. There have been multiple efforts to determine how VacA interacts with 
membranes. A major question has been, what oligomeric form is the 
physiologically relevant form that creates pores within membranes. 
 Atomic force microscopy of VacA bound to supported lipid bilayers as a 
two-dimensional crystal array first suggested that VacA bound to lipid bilayers as a 
single-layered oligomer forming a hexameric chloride channel (Czajkowsky et al., 
1999; Iwamoto et al., 1999; Tombola et al., 1999a). However, later studies 
indicated VacA bound as a double-layered oligomer (Adrian et al., 2002). 
Therefore, due to the lack of resolution it could not be definitively determined 
whether these oligomers were single- or double-layered and no information on the 
p33 domain could be gleaned.  
 Since VacA has been shown to be an anion specific chloride channel, it 
has been hypothesized that it creates an alpha helical pore. In 2004, Bowie and 
colleagues generated a structural model of the VacA pore (Kim et al., 2004). The 
model used a known anion channel structure, the mechanosensitive channel of 
small conductance, or MscS from Escherichia coli (Kim et al., 2004). MscS is an 
alpha helical chloride channel which contains GXXXG motifs (Bass et al., 2002). 
Using the structure prediction procedure in the Monte Carlo package, they 
determined that both structures had similar residues lining the pore. In MscS the 
anion selective residue is proposed to be Arg-88, a positively charged residue 
located at the top of the pore. Correspondingly, based off the structure predictions, 
Lys-33 of VacA was proposed to be the anion selective residue (Kim et al., 2004). 
Although this model for the VacA pore shares striking similarities to that of a 
known chloride channel, there is still a lack of experimental evidence of the VacA 
pore. 
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Research Objective. 
 VacA is a secreted PFT that transitions from a soluble protein to a 
membrane inserted anion channel to induce multiple cellular effects. This toxin 
does not exhibit and sequence homology to any other toxin of known structure. 
While it is known that the p55 domain of VacA is comprised of a b-helix and a C-
terminal globular domain, the structure of the p33 domain remains unknown. VacA 
also, under neutral conditions, is capable of forming multiple large oligomeric 
complexes. As with the soluble structure of the p33 domain, there is a lack of 
structural knowledge on what the pore of VacA looks like. Work detailed in Chapter 
III shows optimal conditions for VacA s1/i1/m1 insertion into membrane as a 
single-layer hexamer, data that can be utilized towards the determination of a high-
resolution structure of a VacA pore. 
 The work presented here details the highest resolution of a VacA oligomer 
to date at 10 Å resolution. Chapter I will detail negative stain random conical tilt 
(RCT) EM structures at ~15 Å resolution of different VacA oligomers. Chapter II 
investigates the physiological relevant oligomeric form of VacA in order to begin 
understanding pore formation by the toxin. Recent advancements in electron 
microscopy, namely the advent of the direct electron detector (DED), as well as 
improvements in data processing, has allowed for the determination by cryo-EM of 
a 10Å structure of a VacA dodecamer, detailed in Chapter IV. 
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CHAPTER II 
 
STRUCTURAL ANALYSIS OF THE OLIGOMERIC STATES OF 
HELICOBACTER PYLORI VacA TOXIN 
 
Introduction 
Helicobacter pylori is a Gram-negative bacterium that colonizes the human 
stomach (Atherton and Blaser, 2009; Cover and Blaser, 2009; Marshall et al., 
1984) and can lead to the development of peptic ulcer disease, gastric 
adenocarcinoma, or gastric lymphoma (Amieva and El-Omar, 2008; Atherton, 
2006; Suerbaum and Michetti, 2002). Gastric cancer is the second leading cause 
of cancer-related deaths worldwide, and H. pylori is classified as a type 1 
carcinogen by the World Health Organization (Fuchs and Mayer, 1995).  
The major secreted exotoxin of H. pylori is known as VacA, named for its 
ability to induce vacuolation in the cytoplasm of mammalian cells (Boquet and 
Ricci, 2012; Cover and Blanke, 2005; Fischer et al., 2004; Montecucco and de 
Bernard, 2003; Rassow and Meinecke, 2012). Additionally VacA causes a slew of 
cellular responses that include depolarization of membrane, mitochondrial 
dysfunction, autophagy, cell death, activation of mitogen-activated protein kinases, 
and inhibition of T cells (Calore et al., 2010a; Domanska et al., 2010; Galmiche et 
al., 2000; Gebert et al., 2003; Jain et al., 2011; Nakayama et al., 2004; Radin et 
al., 2011; Sewald et al., 2008b; Sundrud et al., 2004; Szabo et al., 1999; 
Terebiznik et al., 2009; Willhite and Blanke, 2004). The mechanisms by which 
these alterations occur are not fully understood, but many require VacA 
intoxication (Calore et al., 2010b; Gauthier et al., 2007; Willhite and Blanke, 2004). 
VacA forms anion-selective channels in planar lipid bilayers and in the plasma 
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membranes of cells, and it is hypothesized that VacA can also form channels in 
endosomal and mitochondrial membranes (Cover and Blanke, 2005; Czajkowsky 
et al., 1999; Iwamoto et al., 1999; Tombola et al., 1999b).  
VacA, secreted as an 88-kDa toxin, consists of two domains, designated 
p33 and p55. The p33 domain is postulated to form the anion-selective channel, 
and both the p33 and p55 domains mediate VacA binding to host cells (Cover and 
Blanke, 2005; Domanska et al., 2010; El-Bez et al., 2005; Gonzalez-Rivera et al., 
2010; McClain et al., 2003; Torres et al., 2005). A 2.4 Å 3D structure of the p55 
domain was determined by X-ray crystallography, but there is no structural 
information on the p33 domain (Gangwer et al., 2007).  
 VacA assembles into a heterogeneous assortment of oligomeric 
“snowflake”-structures, which have been visualized by several approaches  
(Adrian et al., 2002; Czajkowsky et al., 1999; El-Bez et al., 2005; Gonzalez-Rivera 
et al., 2010; Lanzavecchia et al., 1998; Lupetti et al., 1996; Reyrat et al., 1999). 
Mutant VacA proteins that fail to oligomerize lack toxin activity (Genisset et al., 
2006; Ivie et al., 2008; Vinion-Dubiel et al., 1999). The snowflake structures likely 
represent water-soluble forms of the anion-selective membrane channels formed 
by VacA. The highest resolution structures of VacA oligomers thus far (~19 Å) 
were obtained by cryo-negative stain EM (El-Bez et al., 2005). In this previous 
structural analysis, it was not possible to obtain tilt pair images, and therefore the 
3D models relied on a number of modeling techniques to generate structures from 
the heterogeneous images of VacA oligomers (El-Bez et al., 2005). Analysis of the 
X-ray crystallographic structure of p55 together with EM images of the oligomers 
has led to a model of VacA oligomer organization in which the p33 domain 
occupies the inner core of the “snowflakes” and the p55 domain extends outward 
from the central core (Gangwer et al., 2007). However, the cryo-negative stain EM 
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structure contained no details about p33 organization and did not allow an analysis 
of how VacA monomers interact to form oligomers. 
Sequence variations within VacA influence cytotoxicity and are associated 
with distinct pathological responses (Atherton et al., 1995; Rhead et al., 2007). 
Three polymorphic regions have been identified: an N-terminal region that is 
differentially cleaved during toxin export to form either an s1 or s2 variant, an 
intermediate region (i1 or i2) located at the C-terminus of the p33 domain, and a 
middle region (m1 or m2) in the p55 domain that affects receptor binding (Atherton 
et al., 1995; Gangwer et al., 2010; Pagliaccia et al., 1998; Rhead et al., 2007). 
Type s1m1 and s1m2 VacA variants are considered fully active, although the 
s1m2 variant binds to a narrower range of cells (Letley et al., 2003; Pagliaccia et 
al., 1998). Type s2 VacA variants contain a twelve-residue hydrophilic N-terminal 
extension, do not vacuolate cells, and form membrane channels less efficiently 
than s1 variants, moreover, s2 forms of VacA are associated with a very low risk of 
symptomatic gastric disease (Atherton et al., 1995; Letley and Atherton, 2000; 
Letley et al., 2003; McClain et al., 2001b). The mechanism by which these 
additional residues disrupt VacA activity is not well understood.  
Analysis of experimentally constructed VacA mutant proteins has identified 
specific VacA domains and/or residues required for pore formation and 
oligomerization. However, the limited structural understanding of how VacA 
oligomerizes, coupled with the lack of structural information on p33, has made it 
difficult to elucidate the exact roles of these domains or residues in VacA function. 
One mutant, VacA∆6-27, lacks three hydrophobic GXXXG motifs posited to be 
important for pore formation and exhibits a dominant negative phenotype when 
mixed with equal molar ratios of acid activated wild-type (WT) VacA (McClain et 
al., 2003; Vinion-Dubiel et al., 1999).  Although this mutant has previously been 
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structurally characterized, the low resolution and lack of structural detail in the 
central p33 region of the 3D maps made it difficult to mechanistically explain how 
the ∆6-27 mutation disrupts function, and the structural consequences of VacA∆6-
27 interaction with WT VacA were not explored (El-Bez et al., 2005). Another 
mutant, containing a deletion between the p33/p55 domains of VacA, retains cell-
vacuolating activity, and was reported to assemble into predominantly six-sided 
oligomeric structures instead of seven-sided oligomers (Burroni et al., 1998; 
Tombola et al., 2001). 
VacA does not exhibit homology to other known bacterial toxins; therefore, 
there is considerable interest in elucidating the structure of this protein and 
understanding the mechanism of membrane pore formation. Although the toxicity 
of VacA lies in its ability to form channels, a high-resolution 3D structure of 
oligomeric VacA has yet to be determined, creating a large gap in our 
understanding of this toxin and its role in H. pylori pathogenesis. In this study, we 
report the determination of ~15 Å 3D reconstructions of six oligomeric forms of 
VacA. These structures provide the first details of p33 organization in the central 
pore and allow us to generate a structure-based model for how VacA oligomerizes. 
We have also used EM analysis to characterize VacA variants and mutants that 
differ from WT VacA in activity or oligomeric structure, providing structural insights 
into the mechanism by which a dominant negative mutant inhibits the activity of 
WT VacA, and the mechanisms by which VacA oligomerizes and forms membrane 
channels. 
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Results and Discussion 
 Visualization of VacA oligomers by negative stain electron microscopy. WT 
VacA was purified from H. pylori culture supernatant and, as expected, acid-
activated preparations caused vacuolation of epithelial cells (data not shown). 
Negative stain EM analysis of purified WT VacA revealed “snowflake”-like particles 
(Fig. 2-1A), corresponding to morphologies observed in other studies (Adrian et 
al., 2002; Cover et al., 1997; Czajkowsky et al., 1999; El-Bez et al., 2005; 
Lanzavecchia et al., 1998; Lupetti et al., 1996). In contrast to the random 
orientation of VacA in previously described cryo-negative stain images, VacA 
oligomers absorbed in a preferred “en face” orientation on the grids (El-Bez et al., 
2005). If the specimen adsorbs on the carbon film in one or a few preferred 
orientations, the specimen must be tilted in the electron microscope to obtain the 
additional views required for 3D reconstruction. Using this technique, referred to as 
the random conical tilt (RCT) approach, the 3D volume is calculated by back-
projection algorithms (Radermacher et al., 1987). Since in this technique the same 
specimen area is imaged twice, once at a high tilt angle and then again untilted, 
the orientation parameters are uniquely defined and the resulting 3D 
reconstruction is very reliable. This approach is especially useful when examining 
samples, such as VacA, that exist in more than one structural state since we are 
able to classify the distinct conformations using the untilted images then use the 
tilted images to determine the structure. Image pairs of grids containing negatively  
stained VacA were recorded at tilt angles of 55˚ and 0˚. A total of 14,573 pairs of 
particles were selected, and images of the untilted specimens were classified into 
20 class averages (Fig. 2-2A). These class averages showed that while essentially 
all VacA particles adsorbed to the carbon grid in the same orientation, the oligomer 
adopts multiple conformations. As seen previously, the classes revealed VacA  
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Figure 2-1. Characterization of negatively stained VacA oligomers. (A) Raw 
image of VacA particles in negative stain. Scale bar, 50 nm. (B) VacA class 
averages obtained by reference-based alignment and classification. “*” marks 
classes that yielded 3D structures (see Fig. 2-3). Numbers of particles included in 
each class is shown in bottom right corner. Side length of panels, 420 Å. 
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Figure 2-2. Analysis of VacA oligomers in negative stain. (A) Twenty class 
averages obtained by multi-reference alignment and classification of 14,573 VacA 
particle images in negative stain. Number of particles in each projection average is 
shown in the lower right corner of each average. The eight averages for reference 
based alignment (See Fig. 2-1B) are marked with a “*” in the upper left corner. 
Side length of panels, 420 Å. (B) Fourier shell correlation (FSC) was used to 
estimate the resolution of the density map of a VacA dodecamer. Using the FSC = 
0.5 criterion, the map has a resolution of ~10 Å. (C) Structure of VacA oligomer 
shown in Figure 2-4 with no applied symmetry. Structure is rotated along vertical-
axis by 90˚. Scale bar, 5 nm. 
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oligomers that contained six chiral arms (Fig. 2-2A, panel 7 and 8) and oligomers 
that contained six or seven arms arranged in an achiral fashion (El-Bez et al., 
2005). In contrast to previous cryo-negative stain studies, we did not observe 
particles with eight or nine arms. Furthermore, all the averages, even the chiral 
forms, had a visible “spoke”-like density in the center of the oligomers (Adrian et 
al., 2002; El-Bez et al., 2005). From the 20 classes, we selected seven that 
represent distinct conformations and one less well-resolved VacA class (Fig. 2-2A, 
marked with “*”). These were used as references for a cycle of reference-based 
alignment (Fig. 2-1B). The results of the reference-based alignment revealed six 
well-resolved classes (Fig. 2-1B, marked with a “*”) and two classes that contained 
particles with disordered arms. Five of the well-resolved classes contained either 
six or seven achiral arms (Fig. 2-1B, panel 1, 2, 3, 5, and 8), while one class 
showed an oligomer with six chiral arms (Fig. 2-1B, panel 4). As seen in the 
reference-free alignment, all the reference-based classes had visible central 
densities that appear structurally organized. 
To more carefully analyze the structural organization of the VacA 
oligomers, images from the tilted specimens corresponding to each of the eight 
classes were used to calculate 3D reconstructions using RCT (Fig. 2-3) 
(Radermacher, 1994). The 3D structures with six- or seven-fold applied symmetry 
are shown in Figure 2-3, while the same structures without applied symmetry are 
shown in Figure 2-4. Of the eight 3D reconstructions, only tilted particles  
associated with the six well-resolved class averages (Fig. 2-1B, marked with a “*”) 
led to well-defined 3D structures. Structures calculated from particles found in two 
of the classes looked very similar (Fig. 2-3B and C) and could easily be aligned. 
To further improve the reconstruction of a VacA oligomer, the tilted images plus 
10% of the highest correlated zero degree images from these two classes were  
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Figure 2-3. 3D reconstruction of negatively stained VacA oligomers using 
random conical tilt approach. (A-F) VacA organizes into a number oligomeric 
conformations that include both hexamers, dodecamers, and tetradecamers. 
These structures have applied symmetry. Structures are rotated along vertical-axis 
by 90˚. Scale bar, 5 nm.  
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Figure 2-4. 3D reconstruction of negatively stained VacA oligomers without 
applied symmetry. (A-F) Structures of VacA oligomers shown in Figure 2-3 with 
no applied symmetry. Structures are rotated along vertical-axis by 90˚. Scale bar, 
5 nm.  
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Figure 2-5. ~15 Å 3D reconstruction of VacA dodecamer. The structure 
contains two prominent features: extended straight “arms” with a slight kink at the 
distal end and a central “spoke-like” density composed of two distinct globular 
domains separated by a thinner connecting density. Structure rotated around 
vertical axis by 90˚. Scale bar, 5 nm. 
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combined and used to calculate a 3D reconstruction either with or without applied 
6-fold symmetry (Fig. 2-5 and 2-2C). 
 From the presented structures, it is clear that VacA monomers can 
oligomerize into achiral double layer structures containing either six or seven arms 
(Fig. 2-3A, B, C, E, and F and 2-5) or into a chiral hexameric structure (Fig. 2-3D). 
Our statistics show that approximately 8% of the oligomers represent hexamers, 
79% represent dodecamers, and 11% represent tetradecamers (Table 2-1). 
Interestingly, VacA heptamers, although seen previously under negative stain, 
cryo-negative stain and vitrified ice conditions (data not shown), were not observed 
in our analysis, even when we expanded the number of classes to 60 (data not 
shown) (El-Bez et al., 2005; Gonzalez-Rivera et al., 2010). One possible 
explanation stems from our observation that the preferred conformation of VacA 
oligomers in solution shifts over time towards hexameric, dodecameric, and 
tetradecameric forms (data not shown). The structures, regardless of oligomeric 
type, contain two prominent features: extended straight arms with a slight kink at 
the distal end and central “spoke”-like densities. The arms clearly represent the 
VacA p55 domain, leaving the central region to represent the p33 domain 
(Gangwer et al., 2007). The double-layer VacA oligomers contain a well-resolved 
central region on one side of the structure (Fig. 2-3A, B, C, and F and 2-5), 
although there is central density present on both sides when no symmetry is 
applied (Fig. 2-4). Additionally, some of the oligomers appear to contain a “plug” 
that occludes the central hole (Fig. 2-3 and 2-4). It is possible that the less ordered 
face is the one that makes contact with the carbon grid and that the presence of a 
plug either represents unorganized central density or stain accumulation. The 
exception to this observation is the structure of one VacA dodecamer, which does 
not contain any well-resolved central density at the molecular weight threshold  
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corresponding to its calculated mass (1,056 kDa), regardless whether or not 
symmetry is applied (Fig. 2-3E and 2-4E). The six-sided oligomers have a 
diameter of 290 Å. The extended arms are ~95 Å long, while the central region has 
a diameter of 100 Å (Fig. 2-3A-E and 2-5). The central regions for all the 
oligomers, with the exception of the dodecamer shown in Figure 2-3E, contain two 
domains separated by a thinner connecting density (Fig. 2-5 and 2-6A and 2-6C). 
The innermost, central domain has dimensions of ~15 x 15 x15 Å, while the 
domain positioned that extends seamlessly from the arm has dimensions of ~30 x 
25 x 20 Å (Fig. 2-3 and 2-5). The tetradecamer is slightly larger than the six-sided 
oligomers, with an overall diameter of 310 Å and a central region with a diameter 
of 120 Å (Fig. 2-3F); however, the size of the arms and central densities are similar 
to those in the hexameric and dodecameric oligomers. 
 VacA structure and oligomerization. To gain insight into how VacA 
oligomerizes, we placed the 2.4 Å crystal structure of the VacA p55 domain into 
the 3D density maps of the VacA oligomers using the program Chimera (Fig. 2-6A 
and C and 2-7) (Gangwer et al., 2007; Pettersen et al., 2004). As is common for 
negative stained specimens, VacA oligomers were slightly flattened, causing the 
tips of the peripheral arms to appear to be touching, a feature that is less 
pronounced in side views of VacA particles in vitrified ice ((El-Bez et al., 2005) and 
data not shown). Although the flattening in the z-axis limits our ability to map inter-
p55 interactions in double-layered oligomers to specific loops rather than to 
specific amino acids, the distortion was fairly minor since even in the double-
layered VacA oligomers, the p55 structure unambiguously fits into the EM maps. 
Placing the p55 crystal structure into the VacA oligomers (Fig. 2-6 and 2-7) clearly 
shows that the extended arms represent the p55 domain and the central densities 
represent the p33 domain along with regions of p55 that have not been crystallized  
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Figure 2-6. Structural model of the VacA oligomerization process. (A) The 2.4 
Å crystal structure of p55 (PDBID: 2QV3) fits into the straight “arms” of the EM 
map of a VacA hexamer. Subtracting the density of the p55 crystal structure from 
the EM map highlights p33 (gray, central density and spokes) (B) p88 oligomerizes 
into hexamers supported by inter-molecular interactions between the N-terminal 
portions of p33 in adjacent protomers, as well as contacts between p33 and an 
adjacent p55 arm. Blue domains, p33; red domain, p55. Two p88 protomers are 
colored pink and yellow to show p88 protomers interaction. (C) The 2.4 Å crystal 
structure of p55 fits into the straight “arms” of the EM map of a VacA dodecamer. 
For ease of viewing model, the p33 density of only the well-organized side is 
shown. (D) Cartoon of dodecamer formation. Colors the same as in B. (A-D) Scale 
bar, 5 nm. (E) The C-terminal p55 domain forms a straight arm with a kink at the 
end, while the N-terminal p33 domain consists of two globular densities connected 
by a thinner density (blue domains). (F and G) 2.4 Å p55 crystal structure rotated 
90˚ on vertical axis. “*” marks regions of p55 involved in (F) hexamer interactions 
(residues 442-448) and (G) dodecamer and tetradecamer interactions. “1”: 
residues 395-404 and 421-435; “2”: residues 519-530 and 547-559; and “3”: 
residues 645-654 and 687-692 (F-G) Scale bar, 2.5 nm. 
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Figure 2-7. Generating pseudo-atomic models of VacA oligomers. (A-D) The 
2.4 Å crystal structure of p55 1 unambiguously fits into the straight “arms” of EM 
maps of VacA dodecamers and the tetradecamer. Subtracting the density of the 
p55 crystal structure from the EM maps highlights the p33 portion of each oligomer 
(gray, central density and spokes). Scale bar, 5 nm.  
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(residues 312-354) (Fig. 2-6E). As previously predicted, the portion of p33 
contiguous to the p55 domain likely adopts an extended a-helix fold since there is 
no clear demarcation in the density map at the p55-p33 intra-molecular interface 
(Fig. 2-6A, C, and E) (El-Bez et al., 2005).  
 The model of hexameric VacA (Fig. 2-6A) shows that oligomerization 
depends on inter-molecular interactions between the N-terminal portions of p33 in 
adjacent protomers, as well as contacts between p33 of one protomer and an 
adjacent p55 arm of another protomer (Fig. 2-6B, see p88 pink and yellow 
protomers). The interactions between the arms can be mapped to a region 
spanning residues 442-448 of p55 (Fig. 2-6F) and a region of p33 contiguous with 
the p55 β-helix in an adjacent arm. The lack of a high-resolution structure of the 
VacA N-terminus precludes mapping this interaction to specific residues; however, 
we speculate that this region likely includes residues 346 and 347, which are 
important in VacA oligomerization (Ivie et al., 2008). 
 VacA forms double layers through interactions mediated by the many loop 
regions extending from the p55 a-helix (Fig. 2-6C, D, and G). These loops can be 
grouped into three major blocks (Fig. 2-6G) and each oligomeric type uses a 
different block to support double layer formation (Fig. 2-6C and D, Fig. 2-7). 
Although this allows for numerous VacA double layer conformations, the different 
interactions, with the exception of one conformation (Fig. 2-7C), do not have any 
distinct effect on the arrangement of the central p33 domains. This suggests 
structural flexibility within p88 protomers, likely found at regions around the p33-
p55 interface and within the short region connecting the two lobes of the p33 
domain (Fig. 2-6E). The dodecamer lacking a well-defined central density uses 
regions in the C-terminus of p55 to support double layer formation (Fig. 2-7C). 
  49 
 
Perhaps the angle the arms must adopt in this oligomer exceeds the inherent 
flexibility found in p88 disrupting ordered N-terminal p33 interactions. From the 
structural analysis of the numerous VacA oligomer conformations, we propose a 
model where soluble VacA first oligomerizes into hexamers or heptamers and then 
these single layers interact to form double layer structures via structural motifs 
along the arm domains.  
 Structural characterization of VacA mutants and variants. A number of VacA 
variants and mutants have been shown to differ from WT toxin in activity and/or 
oligomeric structural features. For example, both VacA∆6-27 and a VacA s2m1 
chimera lack cell-vacuolating activity; VacA∆301-328 retains vacuolating activity 
(data not shown) but a similar mutant preferentially formed particles with increased 
6-fold symmetry rather than 7-fold symmetry (Burroni et al., 1998; McClain et al., 
2001b; Vinion-Dubiel et al., 1999). To gain a better mechanistic understanding for 
why certain VacA mutants and/or variants are more active than others, we 
examined VacA∆6-27, VacA s2m1, and VacA∆301-328 by negative stain EM and 
particles from the untilted images were subjected to alignment and classification 
(Fig. 2-8 and 2-9). The classes were compared to WT VacA classes using 
difference mapping. In cases where significant differences were detected, 3D 
structures were determined. In addition, we calculated the number of hexameric, 
heptameric, dodecameric, and tetradecameric forms for these variants and/or 
mutants (Table 2-1). In general, WT, ∆6-27, s2m1, and ∆301-328 VacA all formed 
oligomers with 6-fold symmetry more frequently than 7-fold symmetry and more 
double layer oligomers than single layer oligomers (Table 2-1). Consistent with a 
previous report, the ∆301-328 mutation leads to an increased proportion of 
oligomers with 6-fold symmetry, but what was not previously appreciated is that 
these oligomers also contain 50% fewer single layer oligomers when compared to  
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Figure 2-8. Characterization of VacA∆6-27. (A) VacA∆6-27 class averages 
obtained by reference-based alignment and classification. “*”, class shown as a 3D 
volume in panel D. (B and C) Difference mapping between WT and similar 
VacA∆6-27 class averages. Final panel shown at 3s threshold. (A-C) Side length 
of panels, 573 Å. (D) 3D structure of VacA∆6-27 corresponding to the “*” average 
in A. Structure has no applied symmetry. Scale bar, 5 nm. (E) Class averages of 
VacA oligomers generated by mixing WT VacA and VacA∆6-27. “*”, classes used 
in difference mapping shown in panel F and G. (F and G) Difference mapping 
between WT VacA and mixture of WT:VacA∆6-27 oligomers. Final panel shown at 
3s threshold. (E-G) Side length of panels, 420 Å. Numbers of particles included in 
each class, bottom right corner. 
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Figure 2-9. Reference-based alignment of VacAΔ301-328 and VacA s2m1.  (A) 
VacAΔ301-328 class averages obtained by reference-based alignment and 
classification. (B) VacA s2m1 class averages obtained by reference-based 
alignment and classification. Side length of panels, 420 Å. Numbers of particles 
included in each class, bottom right corner. 
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WT VacA (Burroni et al., 1998). Interestingly, s2m1, a VacA variant lacking cell-
vacuolating activity, forms single layer oligomers approximately three-times more 
often than WT VacA (Table 2-1, 24% vs. 8%) and six-times more frequently than 
VacA∆301-328 (Table 2-1, 24% vs. 4%). These analyses suggest that whether 
VacA forms single or double layer oligomers in solution is not a key determinant of 
VacA activity. 
 As seen previously, VacA∆6-27 double layer oligomers clearly lack density in 
the p33 region (Fig. 2-8A, B, C, and D) (El-Bez et al., 2005). We now show that the 
central density is absent in both single and double layer oligomers (Fig. 2-8B and 
C). To carefully examine the structural consequences of the ∆6-27 mutation, we 
determined the 3D structure of VacA∆6-27 using the RCT approach, with one 
representative structure shown in Figure 2-8D (Radermacher, 1994). For all 
calculated structures, the central region of each oligomer was no longer 
structurally organized. We propose a model in which deletion of residues 6-27 
leads to the disruption of important interactions between the N-termini of p33 
domains in the oligomers, causing the N-terminal globular domains of p33 to no 
longer adopt an organized central core in any oligomeric form.  
 VacA∆6-27 can inhibit WT VacA activity in a dominant negative manner, but 
the mechanism is not completely understood (Vinion-Dubiel et al., 1999). It has 
been proposed that this inhibitory activity arises from interaction of VacA∆6-27 with 
WT VacA and formation of mixed oligomers with defective activity (McClain et al., 
2001b; Torres et al., 2006; Vinion-Dubiel et al., 1999). To determine whether VacA 
oligomers that contain a mixture of WT and VacA∆6-27 p88 subunits have a 
structurally organized central density, we mixed WT VacA and VacA∆6-27 in a 1:1 
molar ratio, acidified the preparation to pH 3.5 to promote oligomer disassembly, 
and then neutralized the pH to promote oligomer formation (Vinion-Dubiel et al., 
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1999). These oligomers were analyzed by negative stain EM. A total of 22,242 
particles were selected, and images were classified into 20 class averages (Fig. 2-
8E).  Although these classes show that oligomers containing mixtures of WT and 
∆6-27 VacA do seem to have central density, difference maps generated between 
a common hexamer and dodecamer class (Fig. 2-8F and G) show that the central 
density is not as well organized as that found in WT oligomers. This finding 
provides evidence supporting a model in which the 6-27 deletion disrupts 
important N-terminal p33 interactions required for organizing the central core, and 
supports a model in which the dominant negative mutant acts through the 
formation of mixed oligomers with defects in channel formation (Vinion-Dubiel et 
al., 1999). To ensure that these changes in the central organization are specific 
and not simply the result of a general change of structural conformation due to the 
deletion of residues, we also compared WT VacA averages with averages of 
VacA∆301-328 and found no statistical differences (Fig. 2-9A and data not shown). 
 To determine whether the lack of an organized central core is a common 
feature found in variants and mutants of VacA that have defects in pore formation, 
we compared WT VacA averages with averages of VacA s2m1 and found no 
statistical differences (Fig. 2-9B and data not shown). This was especially 
surprising considering that s2m1 VacA contains 12 extra residues at its N-
terminus, which we expected would disrupt the central core in a manner similar to 
what was observed with the VacA∆6-27 mutant (Letley and Atherton, 2000; Letley 
et al., 2003; McClain et al., 2001b). The presence of an intact central core in s2m1 
oligomers is notable because many wild-type H. pylori strains produce s2 forms of 
VacA (Atherton et al., 1995). These data suggest that, unlike VacA∆6-27, the lack 
of vacuolating activity exhibited by VacA s2m1 does not arise from a disorganized 
p33 region, at least in solution. It is possible that the N-terminal extensions may 
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interfere with important hydrophobic interactions between p33 and lipids that are 
required for pore-formation in the context of a membrane environment. 
 In summary, we have analyzed how soluble VacA forms single and double 
layer oligomers and have provided the most detailed structural model of VacA to 
date.  Our analysis of different VacA mutants and variants provides further insight 
into VacA structure-function relationships and the mechanism by which a dominant 
negative mutant exhibits inhibitory activity. There have been three published 
examples of VacA oligomers associated with supported lipid bilayers; however, the 
low resolution of these studies have made it difficult to conclude which oligomeric 
type of VacA associates with lipids (Adrian et al., 2002; Czajkowsky et al., 1999; 
Geisse et al., 2004). It is tempting to speculate that VacA hexamers (Fig. 2-3D) 
represent the conformation that associates with lipids and forms pores, while the 
dodecamers and tetradecamers (Fig. 2-3A, B, C, and F) represent interactions 
between hydrophobic regions of p88 that would normally interact with the lipid 
membrane if present. In future studies, it will be important to analyze the structure 
of VacA oligomers at a higher level of resolution, of VacA oligomers associated 
with lipids, and to investigate structural changes in VacA that are required for the 
formation of membrane channels. 
 
Material and Methods 
 Purification of VacA. H. pylori strain 60190 [expressing WT VacA] and strains 
expressing either VacAD6-27 or VacA s2m1 proteins have been described 
previously (McClain et al., 2001b; Vinion-Dubiel et al., 1999). An H. pylori strain 
expressing a VacAΔ301-328 mutant was constructed using previously described 
methodology (Gonzalez-Rivera et al., 2012). Strains were grown in broth culture 
and VacA was isolated in oligomeric form as previously (Cover et al., 1997; Vinion-
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Dubiel et al., 1999). VacA was further purified using Matrex affinity gel and gel-
filtration chromatography as described (Adrian et al., 2002). Mixed WT 
VacA:VacA∆6-27 oligomers were generated by mixing equal molar ratios of WT 
VacA and VacA∆6-27 at neutral pH. The pH was acidified to 3.5 to promote 
oligomer disassembly and the tube lightly vortexed (Vinion-Dubiel et al., 1999). 
The pH of the mixture of was neutralized so that the mixed oligomers could form. 
Specimen preparation and electron microscopy. Uranyl formate (0.7% w/v) 
was used for conventional negative staining as described (Ohi et al., 2004). For 
further details see Supplemental Data. Images of WT VacA, VacA Δ301-328, 
VacA s2m1, and WT: VacA∆6-27 were taken using a F20 electron microscope 
(FEI) equipped with a field emission gun at an acceleration voltage of 200 kV 
under low-dose conditions at a magnification of 62,000X using a defocus value of 
–1.5 µm and recorded on a 4k x 4k Gatan CCD camera. Images were converted to 
mrc format, and binned by a factor of 2 resulting in final images with 3.5 Å/pixel. 
Images of WT VacA (used for difference mapping with VacA∆6-27 particles) and 
VacA∆6-27 were recorded using a Tecnai T12 electron microscope (FEI) equipped 
with a LaB6 filament and operated at an acceleration voltage of 120 kV. Images 
were taken under low-dose conditions at a magnification of 67,000X using a 
defocus value of –1.5 µm. Images were recorded on DITABIS digital imaging 
plates (Pforzheim, Germany). The plates were scanned on a DITABIS micron 
scanner (Pforzheim, Germany), converted to mixed raster content (mrc) format, 
and binned by a factor of 2 yielding final images with 4.48 Å/pixel. All binned MRC 
files were converted to SPIDER format using EM2EM. Image analysis for all VacA 
samples was carried out with SPIDER and the associated display program WEB 
(Frank et al., 1996). 
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 Classification and random conical tilt reconstruction of negatively stained 
WT, variant and mutant VacA particles. Micrograph tilt pairs of WT and ∆6-27 
VacA were recorded at 55˚ and 0˚. Images for VacA s2m1, and VacAΔ301-328 
and the mixture of VacA:VacA∆6-27 particles were collected at 0˚. Particle pairs 
(14,573 for WT VacA and 4,470 for VacA∆6-27 and particles for s2m1, VacAΔ301-
328, and VacA:VacA∆6-27 (7,032 for VacA s2m1, 6,342 for VacAΔ301-328 and 
22,242 for VacA:VacA∆6-27 were selected interactively using WEB. VacA particles 
were windowed into 120 x 120 pixel images (3.5 Å/pixel for WT, VacA s2m1, 
VacAΔ301-328 and the VacA:VacA∆6-27 mixture; 4.48Å/pixel for VacA∆6-27). 
The untilted images were rotationally and translationally aligned and subjected to 
10 cycles of multi-reference alignment and K-means classification. Particles of WT 
VacA were grouped into 20 classes (Fig. 2-2A). The references used for the first 
multi-reference alignment were randomly chosen from the raw images. From the 
class averages eight representative projections were chosen and used as 
references for another cycle of reference based alignment (Fig. 2-2A marked with 
‘*’). Particles of VacA∆6-27 were grouped into 10 classes (Fig. 2-10A) and from 
these class averages seven representative projections were chosen and used as 
references for another cycle of reference based alignment (Fig. 2-10A marked with 
a ‘*’). Particles of VacA s2m1 and VacAΔ301-328 were grouped into 60 classes 
(Fig. 2-10B and C) and from these class averages 10 representative projections 
were chosen and used as references for another cycle of reference based 
alignment (Fig. 2-10B and C marked with a ‘*’). Particles of VacA:VacA∆6-27 were 
grouped into 20 classes (Fig. 2-8E). Difference images were calculated using both 
Diffmap.exe and Spider (Frank et al., 1996). Results were similar using either 
program.  
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Figure 2-10. Analysis of VacA variants in negative stain. (A-C) Class averages 
obtained by multi-reference alignment and classification of 4,470 VacAΔ6-27 (A), 
7,032 VacA s2m1 (B), and 6,342 VacAΔ301-328 (C) particle images in negative 
stain. Number of particles in each projection average is shown in the lower right 
corner of each average. Averages used for reference based alignments (See Figs. 
2-8A and 2-9A and B respectively) are marked with a “*” in the upper left corner. 
Side length of panels, 573 Å (A) and 420 Å (B and C). 
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 The tilted images corresponding to each of the WT and VacA∆6-27 classes 
generated from reference-based alignment were used to calculate initial 3D 
reconstructions by back-projection using the in-plane rotation angles determined 
by rotational alignment and the pre-selected tilt angle of 55˚ implemented in the 
processing package SPIDER (Frank et al., 1996). The density maps were 
improved by back-projection and angular refinement in SPIDER. 10% of the 
particles selected from the images of the untilted specimens in each class were 
included in the data set and angular refinement was repeated. During the angular 
refinement process either 6- or 7-fold symmetry was applied to the final 
reconstructions as determined by the number of “arms” in each oligomeric form. 
Structures with no applied symmetry are shown in Figure 2-4. For further details 
about structural methods used in this analysis refer to Cheng et al (Cheng et al., 
2006). 
 For WT VacA, two of the WT structures were very similar (Fig. 2-3B and C) 
and, therefore the 6,059 particles associated with these structures were combined 
and a new structure was calculated using angular refinement (Fig. 2-5). The FSC 
curve corresponds to normalized cross-correlation coefficients of Fourier shells 
from even and odd particles within the dataset. Using a FSC = 0.5 criteria the  
resolution is ~10 Å (Fig. 2-2B); however, the lack of any secondary structural 
details in our map suggests that the resolution more likely falls closer to 15 Å. This 
resolution corresponds to the appearance of the crystal structure of VacA p55 
when filtered to 15 Å resolution (data not shown) (Gangwer et al., 2007). For 
display purposes structures were filtered in chimera using the “Hide Dust” 
command to diminish ‘salt and pepper’ noise from the maps by removing single 
voxels that were unconnected to the main volume of the 3D density (Pettersen et 
al., 2004). Contouring thresholds were chosen to match the molecular weight for 
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each VacA oligomer. Surface rendering of the structure was performed with the 
program Chimera (Pettersen et al., 2004). 
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CHAPTER III 
 
STRUCTURAL ORGANIZATION OF MEMBRANE-INSERTED HEXAMERS 
FORMED BY HELICOBACTER PYLORI VacA TOXIN 
 
Introduction 
Helicobacter pylori is a Gram-negative bacterium that colonizes the human 
stomach and causes gastric inflammation, leading to the development of peptic 
ulceration and gastric cancer in a subset of infected individuals (Atherton and 
Blaser, 2009; Cover and Blaser, 2009; Marshall et al., 1984; Suerbaum and 
Michetti, 2002). H. pylori infects about 50% of humans (more than 3 billion people), 
with a prevalence as high as 90% in some developing nations (Amieva and El-
Omar, 2008; Atherton, 2006; Nomura et al., 1991; Parsonnet et al., 1991a; 
Suerbaum and Michetti, 2002). Gastric cancer is the third leading cause of cancer-
related deaths worldwide (de Martel et al., 2012; Fuchs and Mayer, 1995). H. 
pylori-associated gastric adenocarcinoma is a rare example of a human cancer 
attributed to a specific bacterial infection, a connection that led the World Health 
Organization to classify H. pylori as a type 1 carcinogen (Anonymous, 1994).  
One of the major virulence factors secreted by H. pylori is the pore-forming 
exotoxin VacA (vacuolating cytotoxin A), named for its ability to induce the 
formation of large vacuoles in eukaryotic cells (Cover and Blanke, 2005). VacA 
causes multiple cellular effects that include cell vacuolation, depolarization of 
membrane potential, mitochondrial dysfunction, autophagy, cell death, activation of 
mitogen-activated protein kinases, and inhibition of T cell activities (Calore et al., 
2010b; Cover and Blanke, 2005; Domanska et al., 2010; Galmiche et al., 2000; 
Gebert et al., 2003; Jain et al., 2011; Nakayama et al., 2004; Radin et al., 2011; 
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Sundrud et al., 2004; Szabo et al., 1999; Terebiznik et al., 2009; Willhite and 
Blanke, 2004). Most VacA-induced cellular alterations require oligomerization of 
the toxin, insertion into the lipid bilayer to form a membrane channel, and 
internalization into the cell (Calore et al., 2010a; Czajkowsky et al., 1999; Gauthier 
et al., 2007; Genisset et al., 2006; Ivie et al., 2008; Iwamoto et al., 1999; Szabo et 
al., 1999; Tombola et al., 1999b; Vinion-Dubiel et al., 1999; Willhite and Blanke, 
2004). The molecular mechanisms underlying each of these steps and the order in 
which they occur are not understood. 
VacA does not exhibit sequence relatedness to any other known bacterial 
toxins. Secreted as an 88 kDa protein, VacA contains an N-terminal p33 domain 
and a C-terminal p55 domain. Three polymorphic regions have been identified: an 
N-terminal region (s1 or s2), an intermediate region (i1 or i2) located within the p33 
domain, and a p55 mid-region (m1 or m2) (Atherton et al., 1995; Gangwer et al., 
2010; Pagliaccia et al., 1998; Rhead et al., 2007). Sequence variations at the N-
terminus (s1 or s2) and within the p55 mid-region (m1 or m2) are associated with 
differences in the ability of VacA to form pores or differences in the binding of 
VacA to cells, respectively (Atherton et al., 1995; Ji et al., 2000; Letley and 
Atherton, 2000; McClain et al., 2001b; Pagliaccia et al., 1998; Sewald et al., 
2008b; Wang et al., 2001). Sequence variation in the p33 intermediate-region and 
p55 mid-region may modulate differences in cellular tropism (Gonzalez-Rivera et 
al., 2012; Ji et al., 2000; Pagliaccia et al., 1998; Rhead et al., 2007; Wang et al., 
2001). The vacA genotype of a strain is strongly associated with the risk of peptic 
ulceration and gastric cancer, and the various forms of VacA differ in activity in 
vitro. Specifically, humans infected with H. pylori strains containing vacA s1/i1/m1 
alleles have an increased risk of developing gastric cancer compared to individuals 
who are infected with H. pylori strains containing vacA s2/i2/m2 alleles (Atherton et 
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al., 1995; Cover, 2016; Figueiredo et al., 2002; Memon et al., 2014; Rhead et al., 
2007). 
VacA forms anion-selective channels in planar lipid bilayers, an activity that 
correlates with the predicted formation of VacA channels in the plasma membrane, 
endosomal membranes, and mitochondrial membranes of host cells (Campello et 
al., 2002; Czajkowsky et al., 1999; Debellis et al., 2001; Galmiche et al., 2000; 
Iwamoto et al., 1999; Papini et al., 1998a; Papini et al., 1998b; Szabo et al., 1999; 
Tombola et al., 1999a; Tombola et al., 1999b; Willhite and Blanke, 2004; Willhite et 
al., 2003). Single channel analyses have provided evidence predicting that VacA 
pores are composed of six subunits and that they mimic the action of endogenous 
anion-selective channels (Czajkowsky et al., 1999; Domanska et al., 2010; 
Iwamoto et al., 1999; Tombola et al., 1999a). Deep-etch electron microscopy (EM) 
and atomic force microscopy (AFM) have been utilized to visualize VacA bound to 
mica-supported lipid bilayers, but these studies were not able to conclusively 
determine either the type(s) of oligomers bound to the membrane or the 
conformation of the central pore-forming region of VacA in this lipid environment 
(Adrian et al., 2002; Czajkowsky et al., 1999; Geisse et al., 2004). Thus, very little 
is known about structural features of membrane-bound VacA. 
The amino-terminus of VacA (within the p33 domain) is predicted to be 
highly hydrophobic (McClain et al., 2003; Vinion-Dubiel et al., 1999). A VacA 
mutant protein lacking a portion of this region (VacA ∆6-27) does not form pores in 
planar lipid bilayers and lacks cell-vacuolating activity, which indicates that 
sequences within the N-terminal hydrophobic region of the VacA p33 domain are 
required for the formation of membrane channels (McClain et al., 2001a; Vinion-
Dubiel et al., 1999). The N-terminal portion of the p33 domain contains three 
GXXXG sequences, a motif often involved in facilitating oligomeric interactions 
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between transmembrane (TM) helices (Russ and Engelman, 2000; Teese and 
Langosch, 2015). A computationally generated structural model of the predicted 
VacA TM domain sequence suggests that the N-terminal GXXXG motifs pack 
together to form an anion-channel (Kim et al., 2004). Studies using genetically 
modified VacA show that the N-terminal 32 hydrophobic residues of p33, 
especially the proline residue at position 9 (P9) and the G14XXXG18 motif, are 
required for channel activity and cell-vacuolating activity (McClain et al., 2001a; 
McClain et al., 2003). These studies also showed that the GXXXG motifs facilitate 
dimerization in the context of membrane based on experiments using a TOXCAT 
system, a method developed to study TM helix-helix associations (McClain et al., 
2001a; McClain et al., 2003; Russ and Engelman, 1999, 2000). 
In solution, VacA forms hexamers, heptamers, dodecamers and 
tetradecamers, with the majority of soluble oligomers (>90%) organizing into 
double layered structures (dodecamers and tetradecamers) (Adrian et al., 2002; 
Chambers et al., 2013; Lanzavecchia et al., 1998; Lupetti et al., 1996). Although 
there is no atomic resolution structure of the 88 kDa VacA holotoxin, there is a 2.4 
Å three-dimensional (3D) structure of the p55 domain, and 3D structures of 
“snowflake”-like soluble VacA oligomers have been determined using negative 
stain EM (Chambers et al., 2013; El-Bez et al., 2005; Gangwer et al., 2007; 
Sewald et al., 2008a). Our structural analysis showed that while soluble hexamers 
and heptamers form chiral structures with the “tips” of the snow-flakes all curving 
in the same direction, the dodecamers and tetradecamers are achiral (Chambers 
et al., 2013). VacA p55 domains have been localized to the peripheral arms of 
oligomers, and p33 is localized to the central region of the oligomers (Chambers et 
al., 2013; El-Bez et al., 2005; Gangwer et al., 2007).  
  64 
 
In order to form a functional anion-specific channel, VacA must oligomerize 
and insert into the lipid bilayer (Adrian et al., 2002; Czajkowsky et al., 1999; 
Geisse et al., 2004; Tombola et al., 1999a). However, the mechanisms by which 
these steps occur are not fully understood. In the current study, we show that 
VacA oligomerizes on membranes under buffer conditions that do not support 
oligomerization in solution, and that membrane-bound VacA is also membrane-
inserted. Studies of individual VacA domains show that while p55 can interact with 
membranes, p33 is required for insertion into the lipid bilayer. Importantly, we 
show that VacA organizes into single layered oligomers on membranes, and show 
that the p33 central region of VacA hexamers has a different structural 
organization when comparing membrane-associated hexamers to soluble 
hexamers. These are the first in-depth studies of VacA oligomer conformation in 
the context of membranes and provide important new insights into the process by 
which VacA inserts into membranes.  
 
Materials and Methods 
Purification of H. pylori VacA, p55 recombinant VacA, and 
Schizosaccharomyces pombe Cdc15 F-BAR. H. pylori strain 60190 expressing 
VacA s1/i1/m1 and mutant strains expressing VacA s2/i1/m1 or VacA Δ6-27 have 
been previously described (McClain et al., 2001b; Vinion-Dubiel et al., 1999). 
Strains were grown in Brucella broth supplemented with cholesterol and VacA was 
isolated as previously described (Cover et al., 1997; Jimenez-Soto et al., 2012; 
Vinion-Dubiel et al., 1999). To purify a non-oligomerizing form of VacA, an H. pylori 
strain expressing VacA Δ346-347 was modified so that it produced VacA 
containing an internal strep tag inserted at amino acid 312 (Willhite and Blanke, 
2004; Ye et al., 1999). VacA Δ346-347-Str312 was then purified using Strep-Tactin 
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resin (IBA, Goettingen, Germany). The VacA p55 domain (residues 312-821) was 
expressed in Escherichia coli and purified as described (Gangwer et al., 2007). 
Recombinant S. pombe Cdc15 F-BAR-E30K/E152K was expressed and purified 
as described (McDonald et al., 2015). Recombinant proteins were visualized using 
SDS-PAGE and Coomassie staining. 
Liposome co-pelleting assays. Large unilamellar vesicles (LUVs) were 
generated as described (Itoh et al., 2005), using the following lipid mixtures: 1,2-
dioleoyl-sn-glycero-3-phosphocholine (DOPC); L-α-phosphatidylcholine from egg 
(ePC), 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS), and ovine cholesterol 
(55/15/30 % of total moles (mol%)); DOPC, DOPS, and egg sphingomyelin (eSM) 
(45/20/35 mol%); DOPC, DOPS, eSM, and cholesterol (35/20/35/10 mol%). All 
lipids were purchased from Avanti Polar Lipids (Alabaster, AL). Briefly, lipids in 
chloroform (CHCl3) were mixed at the desired ratios and evaporated under a 
nitrogen stream, further dried in a vacuum overnight, and rehydrated in 10 mM 
HEPES pH 7.2 and 100 mM potassium chloride (KCl) to a final concentration of 1 
mg/mL lipid. Lipid mixtures were vortexed, exposed to three cycles of freeze 
thawing using a dry ice/ethanol bath and 37°C water bath, and then extruded using 
an Avanti extruder with an 800 nm filter. Before being mixed with the LUVs, VacA 
(s1/i1/m1, s2/i1/m1, and Δ6-27) was acid activated by lowering the pH to 3.0 
resulting in disassembly of oligomers as previously described (Cover et al., 1997). 
VacA Δ346-347 was not acid activated since this mutant protein is defective in 
oligomerization and does not require acid-induced disassembly (Ivie et al., 2008). 
Acid activated VacA s1/i1/m1, s2/i1/m1, Δ6-27, Δ346-347, p55, and bovine serum 
albumin (BSA) were mixed at increasing concentrations (µM) with 100 µg LUVs 
and incubated for 15 minutes at 25°C. Samples were spun down using a Beckman 
Coulter (Pasadena, CA) TL-100 ultracentrifuge and TLA-100 rotor at 156,425 x g 
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for 45 minutes at 25°C. The supernatant (unbound sample) was removed and the 
liposome pellet (bound sample) suspended in 10 mM HEPES pH 7.2 and 100 mM 
KCl. Samples were run on 4-12% Bis-Tris SDS-PAGE gels (Invitrogen, Carlsbad 
CA) and stained with Coomassie. Gels were digitized using a CanonScan 8800F 
digital scanner and quantified using ImageJ (Schneider et al., 2012). Each 
liposome co-pelleting assay was repeated three times in independent experiments. 
The percent of VacA bound to membrane was determined by averaging intensity 
measurements of bands corresponding to membrane-bound and unbound VacA. 
Results represent the mean + standard error of the mean (SEM) based on three 
independent experiments. Graphs and statistics were generated using GraphPad 
Prism (version 5.0a). 
VacA insertion assay. VacA s1/i1/m1, s2/i1/m1, ∆6-27, ∆346-347, and p55 
were incubated with ePC/DOPS/chol (55/15/30 mol%) at a lipid-to-protein ratio 
(LPR) of 50:1 (w/w) for 15 minutes at room temperature. Cdc15 F-BAR-
E30K/E152K was mixed with DOPC/DOPS (80/20 mol%) LUVs at a LPR of 5:1 
(w/w) and incubated for 15 minutes at room temperature. Buffer only controls were 
prepared for all protein-lipid samples. Protein-bound liposome samples were 
alkalinized with an equal volume of 0.2 M sodium carbonate (Na2CO3) for 30 
minutes on ice to compete off peripherally bound protein. This treatment strips 
peripheral, but not integral, bound proteins from the membrane (Fossati et al., 
2014). A final concentration of 1.2 M sucrose in 0.1 M Na2CO3 was then added. A 
discontinuous sucrose gradient was prepared with alkalinized protein-liposomes at 
the bottom, followed by layers of 1 M, 0.5 M, 0.25 M, 0.15 M, and 0 M sucrose in 
0.1 M Na2CO3. The gradients were spun at 108,759 x g for 16 hours at 4°C to 
allow flotation of liposomes into lower density fractions (Beckman Coulter, 
Pasadena, CA). Fractions of 700 μL were collected and precipitated with TCA. 
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Samples were hydrated with 10 mM HEPES pH 7.2, 100 mM KCl and 2X SDS 
sample loading dye. Samples were run on a 10% Bis-Tris SDS-PAGE gel (Life 
Technologies) and Coomassie stained. 
Sample preparation for EM analysis. For negative stain single particle EM 
of membrane-bound VacA, LUVs composed of ePC/DOPS/chol (55/15/30 mol%) 
and heart lipid extract in 10 mM HEPES pH 7.2, 100 mM KCl were prepared as 
described above. VacA s1/i1/m1, s2/i1/m1, and Δ6-27 were acid activated by 
lowering the pH to 3.0, mixed with LUVs (either ePC/DOPS/chol or heart lipids), 
and incubated for 15 minutes at 37˚C. A LPR of 50:1 (w/w) was used for each 
VacA sample (Cover et al., 1997). For analyzing membrane-bound VacA Δ346-
347, LUVs composed of ePC/DOPS/chol (55/15/30 mol%) or 
DOPC/DOPS/eSM/chol (35/20/35/10 mol%) in 10 mM HEPES pH 7.2, 100 mM 
KCl at LPRs of 100:1 (w/w) and 50:1 (w/w), were prepared as described above. 
VacA Δ346-347 was not acid activated prior to mixing with LUVs, since this mutant 
protein is defective in oligomerization and does not require acid-induced 
disassembly (Ivie et al., 2008). Grids containing soluble VacA s1/i1/m1, s2/i1/m1, 
Δ346-347, and Δ6-27 were made as described (Chambers et al., 2013). To 
visualize soluble monomeric VacA s1/i1/m1, the pH of the sample was lowered to 
3.0 before making grids.  
Electron Microscopy (EM). For negative stain EM grids, samples were 
adsorbed to a glow discharged 200-mesh copper grid covered with carbon-coated 
collodion film (EMS, Hatfield, PA). Grids were washed in two drops of water and 
stained with two drops of uranyl formate (0.75%) (EMS, Hatfield, PA) as described 
(Ohi et al., 2004). Samples were visualized on a Tecnai TF20 electron microscope 
(FEI, Hillsboro, OR) equipped with a field emission gun at an acceleration voltage 
of 200 kV under low-dose conditions. Images were taken at a magnification of 
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62,000x at a defocus value of -1.5 μm and recorded on a 4k x 4k CCD Ultrascan 
camera (Gatan, Pleasanton, CA). Images were converted to mixed raster content 
(mrc) format and binned by two, resulting in final images with a pixel size of 3.5 
Å/pixel. Images of VacA ∆346-347-LUVs were taken on a FEI Morgagni (FEI, 
Hillsboro, OR) equipped with a tungsten filament at an acceleration voltage of 
100kV and a magnification of 28,000x. 
Classification and difference mapping. Particles were selected interactively 
using BOXER in the program EMAN and windowed into 120 x 120 pixel images 
(42 nm x 42 nm) (Ludtke, 2010). Boxed particles were rotationally and 
translationally aligned and subjected to ten rounds of reference free alignment 
using the program SPIDER (Shaikh et al., 2008). Datasets used include: 5,763 
particles for soluble VacA s1/i1/m1; 2,207 particles for VacA s1/i1/m1-
ePC/DOPS/chol LUVs; 3,800 particles for VacA s1/i1/m1-heart lipid LUVs; 2,142 
particles for VacA s2/i1/m1-ePC/DOPS/chol LUVs; 2,919 particles for s2/i1/m1-
heart lipid LUVs; 4,186 particles for VacA Δ6-27; 2,429 particles for VacA Δ6-27-
ePC/DOPS/chol LUVs; and 2,111 particles for VacA Δ6-27-heart lipid LUVs. Four 
or five representative averages for each VacA variant were chosen and particles 
were subjected to reference based alignment. 2D averages of soluble and 
membrane-bound oligomers were compared by generating and then overlaying 
radial density distribution plots of normalized 2D averages as described (Dang et 
al., 2005b). Averages were normalized and values for the radial density distribution 
plots and difference maps were calculated using the program SPIDER (Shaikh et 
al., 2008). 
Results 
VacA s1/i1/m1 oligomerizes as chiral hexamers on membranes. As an 
initial step towards characterizing the structural organization of membrane-bound 
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VacA, we first confirmed VacA’s ability to bind vesicles using lipid compositions 
previously used in planar lipid bilayer experiments that characterized VacA 
channel activity (Czajkowsky et al., 1999; Iwamoto et al., 1999; Tombola et al., 
1999a; Vinion-Dubiel et al., 1999). For these assays, 0.8 µM of VacA s1/i1/m1 was 
acid activated to disassemble soluble oligomers into monomers and then mixed 
with liposomes composed of DOPC, ePC/DOPS/chol (55/15/30 mol%), 
DOPC/DOPS/eSM (45/20/35 mol%), or DOPC/DOPS/eSM/chol (35/20/35/10 
mol%) before being pelleted by centrifugation (Cover et al., 1997; Molinari et al., 
1998). BSA at 1.1 µM was used as a negative control to measure non-specific 
membrane binding. Each binding experiment was done in triplicate and samples 
were analyzed by Coomassie staining, quantifying VacA or BSA in the supernatant 
(unbound) and the vesicle pellet (bound) (Fig. 3-1). The results show that VacA 
s1/i1/m1 bound to all lipid compositions tested (Fig. 3-2A). Statistically significant 
differences in VacA binding to specific lipid compositions were detected, but the 
differences in magnitude were small and probably not biologically meaningful (Fig. 
3-2A).  The negative control BSA did not bind the liposomes (Fig. 3-2B).  
AFM, deep-etch EM, and 2D crystallization techniques have been used to 
visualize VacA s1/i1/m1 associated with membranes (Adrian et al., 2002; 
Czajkowsky et al., 1999; Geisse et al., 2004; Vinion-Dubiel et al., 1999). However, 
the limited resolution of the images in these studies made it difficult to determine 
whether the membrane-bound oligomers were single or double layer oligomers 
and impossible to visualize the conformation of the central pore-forming region of  
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Figure 3-1: Liposome co-pelleting assays with VacA s1/i1/m1 and BSA. (A-D) 
VacA s1/i1/m1 binds liposomes composed of DOPC (PC) (A), 
eggPC/DOPS/cholesterol (ePC/PS/chol) (55/15/30 mol%) (B), 
DOPC/DOPS/eggSphingomyelin (PC/PS/SM) (45/20/35 mol%) (C), and 
DOPC/DOPS/eggSphingomyelin/cholesterol (PC/PS/SM/chol) (35/20/35/10 mol%) 
(D). Increasing concentrations of VacA s1/i1/m1 (µM) were added to a constant 
amount of LUVs. + = LUVs present; - = no LUV control. S = supernatant 
(unbound); P = pellet (bound). VacA visualized by Coomassie staining of SDS-
PAGE gel. Gel shown is one of three independent co-pelleting experiments. (E-H) 
BSA does not bind robustly to liposomes composed of PC (E), ePC/PS/chol 
(55/15/30 mol%) (F), PC/PS/SM (45/20/35 mol%) (G), and PC/PS/SM/chol 
(35/20/35/10 mol%) (H). Increasing concentrations of BSA (µM) were added to a 
constant amount of LUVs. + = LUVs present; - = no LUV control. S = supernatant 
(unbound); P = pellet (bound). BSA visualized by Coomassie staining of SDS-
PAGE gel. Gel shown is one of three independent co-pelleting experiments. 
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Figure 3-2: VacA s1/i1/m1 organizes on membranes as hexamers. (A-B) Large 
unilamellar vesicles (LUVs) with various lipid compositions were incubated with 0.8 
µM VacA s1/i1/m1 or 1.1 µM BSA, and the proportion of protein bound to the 
vesicles was determined. p < 0.05, *; p <0.01, **. Results represent the mean + 
SEM based on three independent binding assays. PC: 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC); ePC: L-α-phosphatidylcholine from egg; PS: 1,2-dioleoyl-
sn-glycero-3-phospho-L-serine (DOPS); SM: sphingomyelin from egg; chol: 
cholesterol. (C) Representative negative stain image of VacA s1/i1/m1 bound to 
ePC/DOPS/chol (55/15/30 mol%) LUVs. Scale bar, 50 nm. (D) Representative 
class averages of membrane-bound VacA s1/i1/m1 hexamers. Number of particles 
in each average shown in bottom left. *, marks the average used for comparison 
between soluble and membrane bound VacA s1/i1/m1 hexamers in Figure 2. 
False colored average shows the location of the p55 (red) and p33 (blue) domains. 
Side length of panels, 42 nm   
  72 
 
membrane-bound VacA. To define structural organization of VacA s1/i1/m1 
associated with lipid bilayers, we used negative stain EM to image VacA bound to 
ePC/DOPS/chol (55/15/30 mol%) and heart lipid LUVs (Fig. 3-2C and data not 
shown), two lipid compositions that support formation of anion-selective VacA 
pores (Czajkowsky et al., 1999; Vinion-Dubiel et al., 1999). From this analysis, we 
found that VacA can oligomerize on membranes in an acidic buffer condition (i.e. 
pH of 3) that does not support oligomerization in solution, suggesting that 
monomeric VacA can bind to lipid and then oligomerize (Cover et al., 1997; 
Molinari et al., 1998). From our EM images, we collected datasets of greater than 
2,000 particles for both ePC/DOPS/chol- and heart lipid-bound VacA s1/i1/m1. The 
datasets were classified into 2D class averages using multi-reference alignment 
(Figs. 3-3A-D). Analyses of the resulting classes showed that VacA s1/i1/m1 binds 
to membranes of either composition as an oligomer with six chiral “arms” (Figs. 3-
2D and 3-3A-D). While a small number of oligomers with seven chiral arms were 
observed, there were not enough in the dataset to form a stable class average. 
Oligomers with achiral arms were not detected. Previous studies showed that 
oligomers with six or seven chiral arms correspond to hexamers or heptamers, 
whereas achiral oligomers correspond to dodecamers or tetradecamers (Adrian et 
al., 2002; Chambers et al., 2013; Cover et al., 1997; El-Bez et al., 2005). From 
these data we conclude that VacA s1/i1/m1 assembles on membranes 
predominantly as hexamers.  
Membrane-bound VacA hexamers are structurally distinct from soluble 
oligomers and are inserted into the lipid bilayer. To determine whether there are 
structural differences between soluble and membrane-bound VacA hexamers, we 
compared 2D class averages of the two types of oligomers using radial density 
distribution plots, previously used to  
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Figure 3-3: Negative stain averages of membrane-bound and soluble VacA 
s1/i1/m1. (A) Reference free alignment of 2,207 particles of VacA s1/i1/m1 bound 
to eggPC/DOPS/cholesterol (ePC/PS/chol) (55/15/30 mol%) into ten classes. 
Classes chosen as references marked with “*”. (B) Reference based alignment of 
membrane-bound (ePC/PS/chol) VacA s1/i1/m1. “**” is class shown in Figure 1D. 
(C) Reference free alignment of 3,800 particles of VacA s1/i1/m1 bound to heart 
lipid into 20 classes. Classes chosen as references marked with “*”. (D) Reference 
based alignment of membrane-bound (heart lipid) s1/i1/m1. “**” marks class 
shown in Figure S3B. (E) Reference free alignment of 5,763 particles of soluble 
VacA s1/i1/m1 into thirty classes. “**” marks the class shown in Figures 2A and 
S3A. Number of particles in each class shown in bottom left corner. Side length of 
all panels, 42 nm. 
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visualize differences between pre-pore and pore-formed Perfringolysin O, and 
difference maps (Dang et al., 2005b). Radial density distribution plots were 
generated from normalized 2D class averages of soluble and membrane-bound 
VacA s1/i1/m1 hexamers (Fig. 3-4A,B and 3-3). The plots were overlaid to 
compare the density across the radius of the soluble and membrane-bound 
hexamers (Fig. 3-4C). Additionally, a difference map was generated by subtracting 
the average of the membrane-bound VacA hexamer from the average of the 
soluble VacA hexamer (Fig. 3-5A-C). Both analyses showed that there is less 
density in the central, p33, region of membrane-bound s1/i1/m1 hexamers 
compared to soluble hexamers, suggesting that the p33 pore-forming domain 
undergoes a structural change when associated with membrane. To determine 
whether this difference is membrane composition-specific, we compared the radial 
density distribution plots and a difference map of soluble VacA s1/i1/m1 and VacA 
s1/i1/m1 bound to heart lipid membranes and obtained results similar to what was 
observed for VacA hexamers bound to ePC/DOPS/chol (Fig. 3-5D-G), indicating 
that the gross structural change observed in the central region of membrane-
bound VacA s1/i1/m1 hexamers is not dependent on membrane composition. 
One explanation for decreased central region density of membrane-bound 
oligomers could be that the p33 domains inserted into the lipid bilayer, where they 
would not be visible by negative stain EM analysis; however, it is also possible that 
binding to membrane causes a loss of structural organization in the p33 domain 
which would also lead to a loss of density in the 2D average. Since the negative 
stain 2D averages were not sufficient to definitively differentiate among these  
models, we used alkaline carbonate sucrose gradient centrifugation to test 
whether the membrane-bound VacA hexamers were also membrane-inserted (Fig. 
3-4D). This treatment separates integral membrane proteins from peripheral  
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Figure 3-4: The p33 domain of VacA s1/i1/m1 changes structure when bound 
to membranes. (A-D) Comparison of soluble and membrane-bound VacA 
s1/i1/m1 hexamers. (A) Negative stain 2D average of soluble VacA s1/i1/m1 
hexamers; 243 particles in class. (B) Negative stain 2D average of VacA s1/i1/m1 
bound to ePC/DOPS/chol (55/15/30 mol%) LUVs; 917 particles in class. Same 
average shown in Figure 1D. Side length of averages, 42 nm. (C) Overlapping 
radial density distribution plots of normalized 2D averages of the soluble and 
membrane-bound s1/i1/m1 hexamers shown in panels A and B. Solid line = 
soluble hexamer; dotted line = membrane-bound hexamer. Yellow bar highlights 
the region of maximum difference. (D) Diagram showing the use of sodium 
carbonate stripped membranes to address whether membrane-bound proteins are 
peripheral or integral. Membranes treated with sodium carbonate are loaded at the 
bottom of an alkaline sucrose gradient (the highest density). After centrifugation, 
proteins peripherally associated with membranes remain in the highest density 
fraction, while membrane-inserted proteins float with the membranes into the lower 
density fractions. (E-F) Alkaline sucrose gradient analysis of Cdc15 F-BAR-
E30K/E152K (E) and VacA s1/i1/m1 (F) without (-) or with (+) LUVs. Cdc15 F-
BAR-E30K/E152K was bound to LUVs composed of DOPC/DOPS (80/20 mol%), 
and VacA s1/i1/m1 was bound to LUVs composed of ePC/DOPS/chol (55/15/30 
mol%) before being treated with sodium carbonate and centrifuged in an alkaline 
sucrose gradient. Fractions were collected from top (low density) to bottom (high 
density) and analyzed by SDS-PAGE and Coomassie staining.  
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Figure 3-5: The p33 domain of VacA s1/i1/m1 changes structure when bound 
to membrane. (A) Negative stain 2D average of soluble VacA s1/i1/m1 hexamers; 
243 particles in class. Same class averages as shown in Figure 2A. (B) Negative 
stain 2D average of VacA s1/i1/m1 bound to ePC/DOPS/chol (55/15/30 mol%) 
LUVs; 917 particles in class. Same average shown in Figure 1D. (C) Difference 
map subtracting the average of the membrane-bound VacA hexamer with the 
average of the soluble VacA hexamer. (D) Negative stain 2D average of soluble 
VacA s1/i1/m1 hexamers; 243 particles in class. Same class averages as shown in 
Figure 2A. (E) Negative stain 2D average of VacA s1/i1/m1 bound to heart lipid 
membranes; 1178 particles in class. (F) Difference map subtracting the average of 
VacA hexamer bound to heart lipids with the average of the soluble VacA 
hexamer. Side length of all averages, 42 nm. (G) Overlapping radial density 
distribution plots of normalized 2D averages of the soluble and membrane-bound 
s1/i1/m1 hexamers shown in panels A and B. Solid line = soluble hexamer; dotted 
line = membrane-bound hexamer. Yellow bar highlights the region of maximum 
difference. 
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membrane proteins (Fossati et al., 2014). In this assay, the VacA bound LUVs 
were generated as described above and then treated with sodium carbonate 
before being loaded at the bottom (highest density fraction) of an alkaline sucrose 
gradient. Peripheral membrane-associated proteins are stripped from the LUVs 
under alkaline conditions and pellet in the high density sucrose fractions during 
centrifugation, while membrane-inserted proteins remain bound to the membranes 
and float into the lower density sucrose fractions (Fig. 3-4D). To verify this assay’s 
sensitivity for peripheral membrane binding proteins, we tested a mutant F-BAR 
domain from Schizosaccharomyces pombe Cdc15 (E30K/E152K), which binds but 
does not insert into membranes (McDonald et al., 2015). Cdc15 F-BAR-
E30K/E152K was mixed with DOPC/DOPS (80/20 mol%) and acid activated VacA 
s1/i1/m1 was mixed with ePC/DOPS/chol (55/15/30 mol%) liposomes. Gradient 
fractions were collected from the top (low density) to the bottom (high density) and 
visualized by Coomassie staining on a SDS-PAGE gel. Cdc15 F-BAR-
E30K/E152K sedimented in the highest density fraction, both in the absence and 
presence of liposomes (Fig. 3-4E), as expected for a peripheral membrane binding 
protein. VacA s1/i1/m1 remained in the highest density fraction when no liposomes 
were present, but floated into the lower density fractions in the presence of 
liposomes (Fig. 3-4F). The inability to strip VacA from membranes under alkaline 
conditions indicates that membrane-bound VacA s1/i1/m1 hexamers are 
membrane-inserted. Based on these results and combined with our analysis of the 
2D averages of soluble and membrane-bound s1/i1/m1 hexamers (Fig. 3-4C and 
3-5F,G), we conclude that the structural differences seen between soluble and 
membrane-bound VacA hexamers arise from insertion of the p33 domain into the 
membrane, a step required for pore formation. 
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Oligomerization is not required for insertion into the lipid bilayer. Next we 
investigated whether VacA Δ346-347, a mutant that cannot oligomerize in solution, 
could oligomerize and insert into the lipid bilayer when bound to membrane (Ivie et 
al., 2008). VacA ∆346-347 lacks two residues in the p55 domain (Fig. 3-6A), and 
consequently cannot form soluble oligomers even under neutral conditions, as 
determined by gel filtration and negative stain EM (Fig. 3-6B) (Ivie et al., 2008). 
Importantly, 2D averages of VacA s1/i1/m1 at pH 3 (a condition that causes 
soluble oligomers to disassemble into monomers) and VacA ∆346-347 at pH 7 
were very similar, indicating that the two amino acid deletion in VacA ∆346-347 
does not alter the overall structure of p88 monomers (Fig. 3-6C-E). Using liposome 
co-pelleting assays, we confirmed that VacA ∆346-347 binds to the same liposome 
compositions as those bound by VacA s1/i1/m1 (Fig. 3-6F and Fig. 3-7A-D); 
however, VacA ∆346-347 binds at reduced levels compared to wild-type VacA. We 
visualized VacA ∆346-347 bound to liposomes composed of ePC/DOPS/chol 
(55/15/30 mol%) using negative stain EM. Although VacA ∆346-347 bound to the 
LUVs (Fig. 3-6F), it remained monomeric (Fig. 3-6G). Thus, VacA residues 346 
and 347 are essential for VacA oligomerization, both in solution and in the 
presence of membrane. In addition, the reduced binding of VacA ∆346-347 
compared to wild-type VacA suggests that oligomerization may contribute to VacA-
membrane interaction. 
We next tested whether VacA ∆346-347 acts like a peripheral or integral 
membrane protein using the sodium carbonate extraction vesicle flotation assay. 
In the absence of liposomes, VacA ∆346-347 pelleted in the highest density  
gradient fractions. However, when combined with vesicles, VacA ∆346-347 floated 
into the low density gradient fractions (Fig. 3-6H), indicating the monomeric toxin  
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Figure 3-6: VacA ∆346-347, a non-oligomerizing mutant, can insert into the 
lipid bilayer. (A) Schematic of VacA ∆346-347 mutant. p33 = blue; p55 = red; i1 = 
light blue; m1= black, location of ∆346-347 = yellow. (B) Representative negative 
stain image of soluble VacA ∆346-347. Scale bar, 50 nm. (C-D) 2D average of 
negatively stained acidified VacA s1/i1/m1 monomers (C) and VacA ∆346-347 at 
neutral pH (D). Side length of panels, 22.4 nm. Number of particles in each 
average shown in bottom right corner. (E) Cartoon of p88 to scale with averages in 
C and D. p55 (PDB: 2QV3(Gangwer et al., 2007)) in red, p33 in blue. (F) LUVs 
with various lipid compositions were incubated with 0.8 µM VacA Δ346-347 and 
the proportion of VacA Δ346-347 bound to the vesicles was determined. p <0.01, 
**; p < 0.001, ***. Results represent the mean + SEM based on three independent 
binding assays. PC: 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC); ePC: L-α-
phosphatidylcholine from egg; PS: 1,2-dioleoyl-sn-glycero-3-phospho-L-serine 
(DOPS); SM: sphingomyelin from egg; chol: cholesterol. (G) Representative 
negative stain image of VacA ∆346-347 bound to ePC/DOPS/chol (55/15/30 
mol%) LUVs. Scale bar, 50 nm. (H) Alkaline sucrose gradient analysis of VacA 
∆346-347 without (-) or with (+) LUVs. VacA ∆346-347 alone and bound to 
ePC/DOPS/chol (55/15/30 mol%) LUVs were treated with sodium carbonate and 
centrifuged in an alkaline sucrose gradient. Fractions were collected from top (low 
density) to bottom (high density) and analyzed by SDS-PAGE and Coomassie 
staining  
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Figure 3-7: Liposome co-pelleting assays with VacA ∆346-347, p55, VacA ∆6-
27, and VacA s2/i1/m1. (A-D) VacA ∆346-347 binds liposomes composed of 
DOPC (PC) (A), eggPC/DOPS/cholesterol (ePC/PS/chol) (55/15/30 mol%) (B), 
DOPC/DOPS/eggSphingomyelin (PC/PS/SM) (45/20/35 mol%) (C), and 
DOPC/DOPS/eggSphingomyelin/cholesterol (PC/PS/SM/chol) (35/20/35/10 mol%) 
(D). (E-H) p55 binds liposomes composed of DOPC (PC) (E), 
eggPC/DOPS/cholesterol (ePC/PS/chol) (55/15/30 mol%) (F), 
DOPC/DOPS/eggSphingomyelin (PC/PS/SM) (45/20/35 mol%) (G), and 
DOPC/DOPS/eggSphingomyelin/cholesterol (PC/PS/SM/chol) (35/20/35/10 mol%) 
(H). (I-L) VacA ∆6-27 binds liposomes composed of DOPC (PC) (I), 
eggPC/DOPS/cholesterol (ePC/PS/chol) (55/15/30 mol%) (J), 
DOPC/DOPS/eggSphingomyelin (PC/PS/SM) (45/20/35 mol%) (K), and 
DOPC/DOPS/eggSphingomyelin/cholesterol (PC/PS/SM/chol) (35/20/35/10 mol%) 
(L). (M-P) VacA s2/i1/m1 binds liposomes composed of DOPC (PC) (M), 
eggPC/DOPS/cholesterol (ePC/PS/chol) (55/15/30 mol%) (N), 
DOPC/DOPS/eggSphingomyelin (PC/PS/SM) (45/20/35 mol%) (O), and 
DOPC/DOPS/eggSphingomyelin/cholesterol (PC/PS/SM/chol) (35/20/35/10 mol%) 
(P). For all binding experiments an increasing concentration of protein (µM) was 
added to a constant amount of LUVs. + = LUVs present; - = no LUVs control. S = 
supernatant (unbound); P = pellet (bound). VacA visualized by Coomassie staining 
of SDS-PAGE gel. Gel shown is one of three independent co-pelleting 
experiments.  
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had inserted into the bilayer. This finding shows that oligomerization is not required 
for VacA to transition from a soluble protein to a membrane-inserted protein. 
Role of VacA p55 and p33 domains in membrane binding and 
insertion.With the unexpected finding that VacA can insert into membranes without 
first oligomerizing, we next investigated whether specific VacA domain(s) are 
required for membrane binding and insertion. First we tested whether the p55 
domain alone can bind to membrane. p55 (amino acids 312-821) was expressed 
and purified as described and used in liposome co-pelleting experiments 
(Gangwer et al., 2007). Similar to full length VacA s1/i1/m1, p55 bound to all the 
lipid compositions tested (Fig. 3-8A and 3-7E-H). Using negative stain EM 
analysis, the membrane-bound p55 was not visible (data not shown), consistent 
with the expected failure of membrane-bound p55 to form large oligomeric 
structures. To determine whether p55 binds as a peripheral membrane binding 
protein or inserts into the membrane, p55-bound vesicles were treated with sodium 
carbonate and subjected to centrifugation in an alkaline sucrose gradient. p55 
sedimented in the highest density fraction, both in the absence and presence of 
liposomes (Fig. 3-8B) indicating that it is a peripheral membrane binding protein 
that does not insert into the membrane. These results provide direct biochemical  
evidence that while p55 binds membranes, the p33 domain is required for 
membrane insertion of VacA. 
VacA’s p33 domain contains three GXXXG motifs, is essential for anion-
selective channel formation, and has an altered structure when bound to 
membrane as compared to soluble hexamers (Fig. 3-4A-C), suggesting that it 
binds and inserts into membrane (McClain et al., 2003). Since recombinantly 
expressed p33 is insoluble and only folds correctly in the presence of p55, it was 
not possible to use isolated p33 in our assays. Therefore, to test the contribution of  
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Figure 3-8: The roles of VacA domains in membrane insertion and binding. 
(A) LUVs with various lipid compositions were incubated with 1.3 µM p55 and the 
proportion of p55 bound to the vesicles was then determined. p <0.05, *. Results 
represent the mean + SEM based on three independent binding assays. PC: 1,2-
dioleoyl-sn-glycero-3-phosphocholine (DOPC); ePC: L-α-phosphatidylcholine from 
egg; PS: 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS); SM: sphingomyelin 
from egg; chol: cholesterol. (B) Alkaline sucrose gradient analysis of p55 without (-
) or with (+) LUVs. p55 alone or p55 bound to ePC/DOPS/chol (55/15/30 mol%) 
LUVs were treated with sodium carbonate and centrifuged in an alkaline sucrose 
gradient. Fractions were collected from top (low density) to bottom (high density) 
and analyzed by SDS-PAGE and Coomassie staining. (C) LUVs with various lipid 
compositions were incubated with 0.9 µM VacA ∆6-27 and the proportion of VacA 
∆6-27 bound to the vesicles was determined. Graph represents quantification of 
three independent binding assays. (D) Alkaline sucrose gradient of VacA ∆6-27 
without (-) or with (+) LUVs. VacA ∆6-27 alone or bound to LUVs composed of 
ePC/DOPS/chol (55/15/30 mol%) were treated with sodium carbonate and 
centrifuged in an alkaline sucrose gradient. Fractions were collected from top (low 
density) to bottom (high density) and analyzed by SDS-PAGE and Coomassie 
staining. (E) Representative negative stain image of VacA ∆6-27 bound to 
ePC/DOPS/chol (55/15/30 mol%) LUVs. Scale bar, 50 nm. (F) Representative 
class averages of membrane-bound VacA ∆6-27 hexamers and heptamers. 
Number of particles in each average shown in bottom left. Side length of panels, 
42 nm. 
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the N-terminus and the GXXXG repeats in membrane insertion, we examined the 
ability of VacA ∆6-27, a mutant lacking all three GXXXG repeats, to bind 
membrane, insert into the lipid bilayer, and oligomerize (Vinion-Dubiel et al., 1999). 
The GXXXG repeats are required for channel activity and have been 
computationally modeled to form an α-helix that traverses the membrane and 
participates in toxin oligomerization (Kim et al., 2004; McClain et al., 2003). The 
3D structures of soluble VacA ∆6-27 oligomers lack an organized central density 
(Chambers et al., 2013). VacA ∆6-27 bound to all lipid compositions tested (Figs. 
3-8C and 3-7I-L). To determine whether the three GXXXG motifs are required for 
membrane insertion, VacA ∆6-27 was mixed with liposomes and subjected to 
sodium carbonate extraction followed by centrifugation in an alkaline sucrose 
gradient. VacA ∆6-27 remained in the highest density fraction in the absence of 
liposomes, but surprisingly, this mutant floated with membranes into the low 
density fractions, indicating that it had inserted into the membrane (Fig. 3-8D). 
Therefore, while the GXXXG motifs are required for active pore formation, our 
analysis suggests that these repeats are not the only region of the p33 domain that 
inserts into the membrane (McClain et al., 2003). To explore whether the GXXXG 
repeats are required for VacA oligomerization when bound to membranes, we 
used negative stain EM to visualize membrane-bound VacA ∆6-27. Unlike 
membrane-bound VacA ∆346-347, which remains monomeric (Fig. 3-6G), 
membrane-bound VacA ∆6-27 oligomerized into chiral hexamers (87%) and 
heptamers (13%) (Figs. 3-8E,F and 3-9A-D). Thus, the putative transmembrane N-
terminal GXXXG repeats are not required for either VacA membrane insertion or 
oligomerization. 
 Finally, we investigated the interactions of type s2 forms of VacA with 
membranes. In comparison to type s1 forms of VacA, type s2 VacA variants  
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Figure 3-9: Negative stain averages of membrane-bound VacA ∆6-27 and 
VacA s2/i1/m1. (A) Reference free alignment of 2,429 particles of VacA ∆6-27 
bound to eggPC/DOPS/cholesterol (ePC/PS/chol) (55/15/30 mol%) into ten 
classes. Classes chosen as references marked with “*”. (B) Reference based 
alignment of membrane-bound VacA ∆6-27. (C) Reference free alignment of 2,111 
particles of VacA ∆6-27 bound to heart lipid into 10 classes. Classes chosen as 
references marked with “*”. (D) Reference based alignment of heart lipid 
membrane bound VacA ∆6-27. (E) Reference free alignment of 2,142 particles of 
VacA s2/i1/m1 bound to eggPC/DOPS/cholesterol (ePC/PS/chol) (55/15/30 mol%) 
into ten classes. Classes chosen for references marked with “*”. (F) Reference 
based alignment of membrane-bound (ePC/PS/chol) VacA s2/i1/1m1. (G) 
Reference free alignment of 2,919 particles of VacA s2/i1/m1 bound to heart lipid 
into 20 classes. Classes chosen as references marked with “*”. (H) Reference 
based alignment of membrane (heart lipid) bound s2/i1/m1. Number of particles in 
each class shown in bottom left corner. Side length of all panels, 42 nm.  
  
  86 
 
contain a 12-residue hydrophilic N-terminal extension (Atherton et al., 1995). The 
s2 variants of VacA form ion channels less efficiently than s1 variants, and do not 
vacuolate cells (Atherton et al., 1995; Letley and Atherton, 2000; Letley et al., 
2003; McClain et al., 2001b). The N-terminal extension could potentially ablate 
VacA function by disrupting toxin oligomerization on membranes, blocking 
insertion into the lipid bilayer, and/or altering pore conformation. While 3D 
structural analysis of soluble VacA s2/i1/m1 oligomers found no significant 
differences between soluble s1/i1/m1 and s2/i1/m1 dodecamers and 
tetradecamers, the effect of this extension on VacA interactions with membranes 
has not been tested (Chambers et al., 2013). To investigate this topic, we first 
confirmed that VacA s2/i1/m1 bound to all membrane compositions previously 
assayed (Fig. 3-10A and 3-7M-P). To determine whether the s2 VacA variant can 
insert into the lipid bilayer, VacA s2/i1/m1 bound vesicles were treated with sodium 
carbonate and centrifuged in an alkaline sucrose gradient. VacA s2/i1/m1 
sedimented in the highest density fraction in the absence of liposomes, but when 
added to vesicles it floated with the membranes into the low density fractions (Fig. 
3-10B). Therefore, the 12-amino acid extension does not inhibit membrane 
insertion. Visualizing VacA s2/i1/m1 bound to LUVs using single particle negative 
stain EM showed that the s2 variant oligomerizes into chiral hexamers (80%), 
heptamers (20%) (Fig. 3-10C,D and 3-9E-H), and under certain lipid compositions, 
even octamers (Fig. 3-9H). In contrast, heptamers and octamers were infrequently 
observed under these conditions in experiments with s1/i1/m1 VacA (Fig. 3-2 and 
3-3). Thus, the addition or the deletion of residues at the N-terminus of VacA alters 
the types of membrane-bound oligomers that are able to form. 
 
DISCUSSION 
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Figure 3-10: The N-terminal extension on VacA s2/i1/m1 does not alter 
membrane binding or membrane insertion, but does influence the types of 
oligomers that form. (A) LUVs with various lipid compositions were incubated 
with 0.8 µM VacA s2/i1/m1 and the proportion of VacA s2/i1/m1 bound to the 
vesicles was determined. p <0.01, **. Results represent the mean + SEM based 
on three independent binding assays. PC: 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC); ePC: L-α-phosphatidylcholine from egg; PS: 1,2-dioleoyl-
sn-glycero-3-phospho-L-serine (DOPS); SM: sphingomyelin from egg; chol: 
cholesterol. (B) Alkaline sucrose gradient of VacA s2/i1/m1 without (-) or with (+) 
LUVs. VacA s2/i1/m1 alone or bound to LUVs composed of ePC/DOPS/chol 
(55/15/30 mol%) were treated with sodium carbonate and centrifuged in an 
alkaline sucrose gradient. Fractions were collected from top (low density) to 
bottom (high density) and analyzed by SDS-PAGE and Coomassie staining. (C) 
Representative negative stain image of VacA s2/i1/m1 bound to ePC/DOPS/chol 
(55/15/30 mol%) LUVs. Scale bar, 50 nm. (D) Representative class averages of 
membrane-bound VacA s2/i1/m1 hexamers and heptamers. Number of particles in 
each average shown in bottom left. Side length of panels, 42 nm. 
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Our studies provide the first detailed structural characterization of 
membrane-bound VacA and address the role(s) of specific regions of VacA in  
membrane binding, oligomerization, and membrane-insertion. We show that VacA 
oligomerizes into hexamers when bound to membrane and that this 
oligomerization occurs under pH conditions that do not support oligomerization of 
soluble VacA. Comparison of soluble and membrane-bound VacA hexamers 
reveals a prominent structural difference in the central region of the oligomers. 
Combined with our biochemical results indicating that membrane-bound VacA 
hexamers are also membrane-inserted, we conclude that this structural difference 
results from insertion of the p33 domains into the membrane to form a hexameric 
pore. Importantly, membrane insertion is not dependent on toxin oligomerization.  
Under neutral buffer conditions in solution, we previously showed that 
VacA organizes into a heterogeneous combination of hexamers, heptamers, 
dodecamers, and tetradecamers, with ~90% of soluble VacA found as achiral, 
double layer dodecamers and tetradecamers (Chambers et al., 2013). In contrast, 
we find that membrane-bound VacA s1/i1/m1 organizes mainly into chiral 
hexamers, with no dodecamers or tetradecamers present. The oligomerization into 
membrane-bound VacA hexamers is not dependent on membrane composition, 
since hexamers formed on membranes composed of either DOPC or heart lipids. 
Additionally, membrane-bound VacA hexamers formed independent of whether 
lipid raft components, such as cholesterol and sphingomyelin, were present. Our 
negative stain EM analysis concurs with the results of single channel and 
computational modeling studies that predicted VacA pores would be hexamers 
composed of six subunits (Iwamoto et al., 1999; Kim et al., 2004). The double 
layer oligomers found in solution are presumed to result from hydrophobic 
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interactions between p88 molecules that would normally be made with 
membranes. Altogether, these data indicate that in the presence of membranes, 
VacA monomers organize into stable hexamers and these hexamers form 
membrane-inserted pores. 
It has long been appreciated that maximum toxin activity in vitro requires 
acid activation of purified VacA before it is added to cells (Cover et al., 1997; de 
Bernard et al., 1995; McClain et al., 2000; Molinari et al., 1998; Yahiro et al., 
1999). The need for acid activation has been attributed to changes in VacA 
structure, most notably the disassembly of VacA oligomers in an acidic 
environment, but it has also been proposed that low pH changes the conformation 
of p88 so that it can penetrate the lipid bilayer more efficiently (de Bernard et al., 
1995; McClain et al., 2000; Molinari et al., 1998; Pagliaccia et al., 2000). While 
there are many precedents for toxins undergoing conformational changes upon 
exposure to low pH environments, our results for VacA show that exposure to low 
pH does not lead to a gross structural rearrangement (Boquet and Pappenheimer, 
1976; Choe et al., 1992; Leka et al., 2014; O'Keefe et al., 1992; Pruitt et al., 2010). 
Indeed, 2D class averages of VacA s1/i1/m1 monomers at pH 3 and VacA ∆346-
347 at pH 7 are indistinguishable. Additionally, VacA ∆346-347 still inserts into the 
lipid bilayer at a neutral pH, showing that acid activation is not required for 
membrane insertion. From these results we conclude that the main importance of 
acid activating VacA is to simply dissociate the dodecamers and tetradecamers 
that make up ~90% of the sample at a neutral pH. The released p88 monomers 
can then oligomerize on membranes (perhaps via hydrophobic regions that were 
inaccessible in the double layer oligomers), or alternatively, the monomers may 
bind specific cell surface receptors with increased affinity compared to that of 
oligomerized toxin (Yahiro et al., 1999). Once bound to the membrane, we predict 
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that regions of p33 undergo structural rearrangement(s) that allow VacA to insert 
into the bilayer and oligomerize. 
Multiple lines of evidence suggest that the p33 domain forms the VacA 
anion-selective channel, and both the p33 and p55 domains are involved in VacA 
binding to host cells and oligomerization (Cover and Blanke, 2005; Domanska et 
al., 2010; Gonzalez-Rivera et al., 2010; McClain et al., 2003; Torres et al., 2005). 
Difficulties in purifying properly folded recombinant p33 have made it a challenge 
to examine the individual contributions of the p33 and p55 domains to membrane 
binding, membrane insertion, oligomerization, and pore formation. We found that 
while recombinant p55 binds membranes, it does not oligomerize on membranes 
or insert into the lipid bilayer. In previous studies using the TOXCAT system, a 
method developed to study TM helix-helix associations, the N-terminal 
hydrophobic region of VacA (amino acids 1-32) was found to insert into the 
membrane and drive dimerization (McClain et al., 2001a; McClain et al., 2003; 
Russ and Engelman, 1999, 2000). Conversely, in the current study we found that 
VacA ∆6-27, a mutant lacking all three N-terminal GXXXG repeats, was still able to 
insert into the lipid bilayer. This finding suggests that there are previously 
unrecognized regions of p33 that are important for facilitating the transition of 
VacA from a soluble toxin into an active ion channel; since these regions 
presumably insert into membranes, they could potentially be important structural 
components of the VacA ion channel.  
It is currently not clear which regions in addition to the hydrophobic N-
terminus can insert into the membrane. Analysis of the p33 domain hydrophobicity 
plot does not predict any obvious TM domains in addition to the previously 
recognized GXXXG motifs (McClain et al., 2003; Vinion-Dubiel et al., 1999). 
However, previous studies using VacA deletion mutants to map regions in p33 that 
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are required for oligomerization in solution provided evidence that multiple regions 
of p33 other than the N-terminus contribute to oligomerization (Genisset et al., 
2006; Vinion-Dubiel et al., 1999). Additionally, one study, using a combination of 
proteolytic digestion and mass spectrometry analysis, reported that VacA residues 
40-66, 111-169, 205-266, 548-574 and 723-767 were protected from proteolysis 
because of their interaction with the membrane (Wang et al., 2000). Two of these 
protected peptides (548-574 and 723-767) are in p55, a domain that we show 
does not insert into the membrane. The other three peptides (40-66, 111-169 and 
205-266) are located in the p33 domain, making them possible candidates for 
membrane insertion. Membrane-protected peptides spanning residues 1-32 were 
not detected, leading the authors to suggest that the N-terminus of VacA regulates 
channel formation through an unknown mechanism that does not involve forming 
the actual channel (Wang et al., 2000). While this conclusion is consistent with 
their mass spectrometry results, it does not fit with other studies showing that the 
N-terminus of VacA is required for insertion of the protein into membranes and 
formation of an anion channel (Kim et al., 2004; McClain et al., 2001a; McClain et 
al., 2003; Vinion-Dubiel et al., 1999). High-resolution structural analysis of 
membrane-bound VacA will be needed to elucidate the membrane topology of 
VacA in the context of the lipid bilayer and conclusively define which regions of 
p33 are essential and sufficient for pore formation. 
While the current results show that VacA ∆6-27 can still insert into 
membranes, several lines of evidence indicate that the first 32 amino acids of the 
p33 domain are essential for the formation of a functional ion channel. Deletion of 
amino acids ∆6-27 abrogates the capacity of VacA to form pores in planar lipid 
bilayers and its capacity to cause vacuolation of cells, and mutant proteins 
containing specific point mutations near or in the third G14XXXG18 motif lack 
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channel activity and do not cause cellular vacuolation (McClain et al., 2001b; 
McClain et al., 2003; Vinion-Dubiel et al., 1999). Additionally, VacA s2/i1/m1, a 
mutant that contains a 12-amino acid N-terminal extension, has reduced pore 
activity and does not vacuolate cells (McClain et al., 2001b). Collectively, these 
studies show that the p33 N-terminal region is required for pore formation and is 
sensitive to structural alterations. While the first 32 amino acids are not required 
for oligomerization in solution or on membrane, modifying the VacA N-terminus, 
either by adding or deleting amino acids, alters the ratio of hexamer and heptamer 
formation on membranes (Chambers et al., 2013; El-Bez et al., 2005; Vinion-
Dubiel et al., 1999). Thus, the first 32 amino acids of VacA play at least an 
ancillary role in organizing oligomer formation of membrane-bound VacA. This 
conclusion is consistent with previous studies showing that point mutations made 
in the N-terminus of VacA reduce TM dimerization, as well as the prediction made 
by computational modeling that the GXXXG motifs make numerous intramolecular 
contacts required for the proper organization of a hexameric ion channel (Kim et 
al., 2004; McClain et al., 2001a; McClain et al., 2003).  
In summary, we have shown that membrane-bound VacA assembles into 
hexameric structures, that there is a distinct structural difference in the central 
region of soluble hexamers compared to membrane-bound hexamers, and that 
insertion of VacA into the lipid membrane is not dependent on oligomerization. Our 
findings predict that VacA pore formation requires multiple regions of VacA in 
addition to the N-terminal GXXXG repeats. We propose a model where monomeric 
VacA binds to lipids and the p33 domain inserts into the lipid bilayer to oligomerize 
and form a pore (Fig. 3-11). The insertion of p33 into the membrane leads to a 
clear structural difference between soluble and membrane-bound VacA hexamers.  
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Since oligomerization is not required for p33 to insert into the membrane, 
we propose a model in which 1) VacA monomers bind to membrane, 2) the p33 
domain inserts into the lipid-bilayer, and 3) the pore is formed (Fig. 3-11A). 
However, our data do not resolve questions about the temporal order of 
membrane-insertion, oligomerization, and pore formation. Thus, multiple models 
are possible, including one where VacA membrane insertion and pore formation 
occur concomitantly (Fig. 3-11B). Continuing biophysical and structural analyses of 
membrane-bound VacA s1/i1/m1 and VacA mutants will be essential for dissecting 
the interrelated steps of oligomerization, insertion, and pore formation, and 
elucidating the molecular organization of the VacA anion channel. 
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Figure 3-11: Models of VacA pore formation in membranes. Monomeric VacA 
binds to membrane where regions of p33 insert into the lipid bilayer, either before 
(A) or concomitant (B) with p88 oligomerization into a hexamer forming a 
functional pore. Further biophysical studies are needed to determine the temporal 
order of membrane insertion, oligomerization, and pore formation. p55 depicted in 
red, while p33 is shown in blue.   
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CHAPTER IV 
 
HIGH RESOLUTION STRUCTURAL ANALYSIS OF A HELICOBACTER 
PYLORI VacA TOXIN OLIGOMER 
 
Introduction 
 Helicobacter pylori is a gram-negative bacterium that infects and colonizes 
the human stomach (Atherton and Blaser, 2009; Cover and Blaser, 2009; Marshall 
et al., 1984). This bacterium infects over 50% of the world’s population and its 
presence induces chronic gastritis and can lead to the development of peptic 
ulcers and in more severe cases, gastric lymphoma and adenocarcinoma (Amieva 
and El-Omar, 2008; Atherton, 2006; Suerbaum and Michetti, 2002). The role that 
H. pylori plays in the development of these cancers led the World Health 
Organization to classify it as a type I carcinogen (Anonymous, 1994). 
 One of the major virulence factors secreted by H. pylori is vacuolating 
cytotoxin A (VacA). VacA is named for its ability to induce larges vacuoles in cells 
when infected (Boquet and Ricci, 2012; Cover and Blanke, 2005; Fischer et al., 
2004; Montecucco and de Bernard, 2003; Rassow and Meinecke, 2012). VacA is 
secreted as an 88 kDa monomer and is divided into two domains: an N-terminal 
p33 domain required for receptor binding and pore-formation and a C-terminal p55 
domain reported to be required for receptor binding and specificity (Cover and 
Blanke, 2005; Domanska et al., 2010; El-Bez et al., 2005; Gonzalez-Rivera et al., 
2010; McClain et al., 2003; Torres et al., 2005). A crystal structure of the p55 
domain revealed that it is comprised of a beta helix with a C-terminal globular 
domain (Gangwer et al., 2007). Recently, a crystal structure determined of a 
mutant of p88, VacA D346-347, which contains a two amino acid deletion near the 
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junction of p33 and p55, showed that the beta helix extends into the p33 domain 
(Gonzalez-Rivera et al., 2016). Unfortunately, the N-terminus of the p33 domain 
was unable to be resolved with this analysis and therefore there is still a lack of 
high resolution structural information regarding this domain.  
At neutral pH, VacA forms large water soluble oligomers, or “snowflake” 
like structures, including single-layer hexamers and heptamers and double-layer 
dodecamers and tetradecamers which have been visualized using various 
methods (Adrian et al., 2002; Chambers et al., 2013; Cover et al., 1997; 
Czajkowsky et al., 1999; El-Bez et al., 2005; Gonzalez-Rivera et al., 2010; 
Lanzavecchia et al., 1998; Lupetti et al., 1996; Reyrat et al., 1999). Cryo-negative 
EM structures were determined to ~19 Å and generated using computational 
modeling methods since random conical tilt (RCT) was not performed (El-Bez et 
al., 2005). Most recently, ~15 Å resolution VacA oligomer structures were 
determined using negative stain random conical tilt (RCT) electron microscopy 
(Chambers et al., 2013). Unfortunately, the cryo-negative stain and RCT structures 
were at too low of a resolution to discern any secondary structure detail. However, 
analysis of the p55 crystal structure together with the EM density maps indicated 
that the p55 domain is localized to the arms of the oligomers thus leaving the p33 
domain to comprise the central region (Chambers et al., 2013; Gangwer et al., 
2007; Ivie et al., 2008). 
Previous studies have shown that VacA forms in anion channel in planar 
lipid bilayers (Adrian et al., 2002; Czajkowsky et al., 1999; Geisse et al., 2004; 
Iwamoto et al., 1999; Tombola et al., 1999a). Although VacA does not share any 
sequence similarity to any other chloride channel, the toxin does possess 
characteristics of a typical chloride channel (Iwamoto et al., 1999; Rassow and 
Meinecke, 2012). For example, VacA exhibits a moderate preference for anions 
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over cations and a known channel blocker has uneven blocking power at opposing 
ends of the channel (Iwamoto et al., 1999). VacA also contains 3 GXXXG motifs 
which are known transmembrane motifs and upon deletion of these motifs, 
channel activity is severly diminished (McClain et al., 2001a; McClain et al., 2003; 
Russ and Engelman, 2000; Teese and Langosch, 2015). While a high-resolution 
structure has yet to be determined of the VacA pore, computational modeling has 
been performed (Kim et al., 2004). The model showed similarities with the 
structure of a known chloride channel, mechanosensitive channel of small 
conductance, or MscS, which also contains the GXXXG membrane spanning 
motifs. Both channel structures were found to possess similar pore lining residues 
(Kim et al., 2004). The authors also proposed that the first positively charged 
residue of the channel, Lys-33, may be responsible for pore selectivity (Kim et al., 
2004). Despite these efforts, high resolution structural analysis will be required to 
fully understand VacA pore formation.  
 Since VacA does not have any sequence similarity to any other protein 
toxin of known structure, it is essential that a high-resolution structure of both 
soluble and membrane inserted VacA be determined in order to begin to 
understand the mechanism by which VacA undergoes the transition in order to 
infect cells. Here we report the structure of a VacA dodecamer at 10 Å resolution, 
determined by single particle cryo-EM. 
 
Materials and Methods 
Expression and Purification of VacA. H. pylori strain 60190 expressing 
VacA s1/i1/m1 has been previously described (McClain et al., 2001b). The strain 
was grown in Brucella broth supplemented with cholesterol and VacA oligomers 
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were isolated as previously described (Cover et al., 1997; Jimenez-Soto et al., 
2012). 
Specimen Preparation for Cryo-EM Analysis. VacA s1/i1/m1 was prepared 
as described above and diluted to 75-85 µg/mL in 10 mM HEPES pH 7.2 and 100 
mM potassium chloride (KCl). Cryo-EM grids were prepared using a Mark II/III 
Vitrobot (FEI) at 25°C and 60% humidity. Sample was applied (2-3 µL) to a glow 
discharged Quantifoil R2/1 400 mesh grid (EMS) and blotted for 2-3 seconds prior 
plunging in liquid ethane cooled by liquid nitrogen.  
Image Acquisition. Images were taken on a Tecnai F30 Polara (FEI) 
operating at an acceleration voltage of 300kV and at magnification of 40,109x. 
Images were recorded using a Gatan K2 Summit Direct Electron Detector (DED) 
with a pixel size of 0.624. Images were acquired using super-resolution mode, and 
dose fractionated to 40 frames for a total of eight seconds, 0.25 seconds/frame, 
with a dose rate of 2.5 e-/pix/sec or 5 e-/pix/sec. Images were collected using a 
defocus range of -1.5 to -4.0 µm. Digital Micrograph (Gatan, Inc.) was used for 
data collection. VacA exhibited preferential orientations in ice, therefore, a subset 
of images (1,004) were taken at a tilt angle of 10° to increase particle views. 
Data Processing. Motion correction was performed with Motioncor2 
(Zheng, 2016). A total number of 5,780 images were taken and CTF estimations 
on whole micrographs were determined using Gctf to assess micrograph quality 
(Zhang, 2016). A total number of 210,641 particles were manually selected using 
RELION 1.4 followed by autopicking using Gautomatch (developed by Dr. Kai 
Zhang, Cambridge, UK) without a reference stack applied. After multiple rounds of 
2D classification were performed (particles further binned by 4 at this stage), 
126,239 particles were subjected to 3D classification without symmetry applied 
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followed by two rounds of classification with D6 symmetry applied. The major class 
was identified, with 21,655 particles, and subjected to refinement with a final 
resolution of ~10 Å according to the gold standard FSC (Fig. 4-1). Surface 
rendering of the reconstructions were performed using the program Chimera 
(Pettersen et al., 2004). 
 
Results and Discussion 
This work details the highest resolution structure of a VacA oligomer to 
date. Utilizing the advancements made in cryo-EM with the direct electron detector 
and improved data processing programs, the structure of a VacA dodecamer 
presented here has reached ~10 Å resolution.  
Data analysis reveals that VacA is found in multiple orientations in vitrified 
ice (Fig. 4-2). The first round of 2D classification indicates that the sample is 
heterogeneous, as expected, with hexamers, heptamers, dodecamers, and 
tetradecamers. ‘Junk’ classes were removed and resulting particles were 
subjected to three more rounds of 2D classification. The final round of 2D 
classification exhibited misaligning of particles and also revealed a more 
limitednumber of views than expected (Fig. 4-3). 3D classification was then 
performed without symmetry applied and classes were not well resolved. Classes 
that appeared to be heptamers or tetradecamers were removed and symmetry 
was applied to the remaining rounds of classification. Once symmetry was applied, 
the resolution did improve; however, the structure did not reach below 10 Å  
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Figure 4-1: Data processing schematic. After 2D classification completed, the 
data were subjected to three rounds of 3D classification and then a final 
refinement step on a VacA s1/i1/m1 dodecamer with D6 symmetry applied. 
Numbers below structures represent percent of total number of particles. 
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Figure 4-2: Representative vitrified ice image of VacA s1/i1/m1. Circled 
particles represent different oligomeric forms and views. 
  
  102 
 
resolution (Fig. 4-1 and 4-4A). Despite taking a subset of micrographs at a 10° tilt 
angle to improve particle orientations, the angular distribution shows there is a 
strong preference for front face views of the particles (Fig. 4-4B). Resolution could 
be hindered due to the heterogeneity of the sample. Initial analysis should be 
performed without symmetry applied, but this could potentially require a much 
larger number of particles.  
 Further analysis and refinements need to be performed in order to 
improve the current resolution. Unfortunately, with VacA, a resolution of ~8 Å will 
be required to see the alpha helices postulated to comprise the p33 domain and in 
order to identify the beta helix within the p55 domain, a resolution of ~4 Å is 
necessary. Therefore, in order to understand how VacA oligomerizes and double-
layer formation occurs a resolution of <4 Å needs to be achieved. 
Improvements can be made in resolution for the VacA dodecamer. As 
mentioned, over 200,000 particles have been selected from 5,780 micrographs.  
After the first round of 3D classification, a D6 symmetry was applied to particles 
from the selected classes. There are two complications with this – 1) since the 
resolution was low for round one (~20 Å), there may have been seven sided 
oligomers and 2) there were particles present that are six-sided single-layer  
oligomers as well that do not possess D6 symmetry (Fig. 4-1, first round of 3D 
classification, last class). Applying symmetry at this stage could be hindering 
resolution. Therefore, future efforts should not apply symmetry until the 3D 
refinement step. Ideally, multiple rounds of 3D classification should separate 
different oligomeric forms, then the appropriate symmetry can be applied. 
Once the above steps have been taken to improve the quality and 
resolution of the dataset, masking can be performed to refine the central region of  
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Figure 4-3: 2D classification performed in RELION. Classification shows the 
sample is heterogeneous. Classes are sorted based on distribution, with the first 
class containing the highest number of particles. Particles from * classes saved 
and subjected to 3D classification. Side length of panel, 39.9 nm. 
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Figure 4-4: VacA s1i1/m1 resolution is ~10 Å. A) FSC curve showing resolution. 
At FSC of 0.5, the resolution is ~12 Å and at the gold standard FSC of 0.143 the 
resolution is ~10 Å. B) Angular distribution shows preference for front face views of 
particles.  
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the oligomer. Masking has been shown to optimize resolution by focusing on a 
region of interest and performing a classification solely on this region to obtain the 
most homogeneous population (for example - (Galej et al., 2016)). In the case of 
VacA, the arms of the oligomers should be masked so that only the central region 
is aligned. 
There are other EM processing programs that may be better suited for this 
dataset. For example, FREALIGN and SPARX have both been utilized to 
determine high resolution structures by cryo-EM (Bartesaghi et al., 2014; von der 
Ecken et al., 2015). If after each of these steps has been performed and different 
programs utilized and the resolution has not significantly increased, a larger 
dataset will need to be collected. The sample may be more heterogeneous than 
expected. Also, even with the improvements to data processing, it appears to still 
be difficult to identify whether the side views of the oligomers are six-sided or 
seven-sided oligomers. A larger dataset consisting of ~500,000 particles should be 
collected and the methods described here should be performed.  
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CHAPTER V 
 
DISCUSSION AND FUTURE DIRECTIONS 
 
Discussion 
 This work details the structural analysis of the pore-forming toxin VacA of 
H. pylori. Chapter II focuses on structural characterization of VacA s1/i1/m1 along 
with three other mutants, s2/i1/m1, D6-27, and D301-328. Using RCT negative 
stain EM, the work detailed ~15 Å resolution structures of each oligomeric form. 
Chapter III describes the membrane bound and inserted form of VacA, making 
advancements toward optimal conditions for high resolution structural work of a 
VacA pore. Chapter IV details the highest resolution structure of a soluble VacA 
oligomer to date at ~10 Å due to the advancements of image acquisition and 
processing techniques. 
 A major question surrounding VacA structure has been whether each 
oligomeric form is responsible for pore formation and how pore formation occurs. 
To date, there are three major models for VacA oligomerization and pore formation 
(Fig. 5-1), which are similar to proposed models for other PFTs (Figs. 1-4 and 1-5). 
The first model posits that VacA binds to membrane as a monomer then inserts. 
Next, oligomerization occurs followed by pore formation (Fig. 5-1A). The second 
model posits that VacA first binds as a monomer and oligomerization and insertion 
occur concomitantly with a final step of pore formation (Fig. 5-1B). The final model 
proposes that VacA binds as a monomer then oligomerizes on the membrane. The 
next step is oligomer insertion and prior to pore formation (Fig. 5-1C). Multiple 
studies have investigated how VacA binds to membrane 
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Figure 5-1: Models for VacA oligomerization and pore formation. A) Model 
one proposes monomer binding, insertion, oligomerization, then pore formation. B) 
Model two proposes that VacA binds as a monomer followed by concomitant 
oligomerization and membrane insertion and finally proe formation. C) Model three 
shows VacA monomer binding followed by oligomerization on the membrane. 
Next, the oligomer inserts into the membrane and the pore is formed.  
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(Atherton et al., 1995; Czajkowsky et al., 1999; Iwamoto et al., 1999; Pagliaccia et 
al., 1998; Pyburn et al., 2016; Rhead et al., 2007; Szabo et al., 1999; Tombola et 
al., 1999b). VacA applied to supported lipid bilayers combine with AFM strongly 
suggested that VacA bound to the bilayers as a single-layer hexamer (Czajkowsky 
et al., 1999). More recently, it was found that when applied to large unilamellar 
vesicles (LUVs), VacA bound to the LUVs as a single-layer hexamer and further 
analysis showed that it was inserted into the lipid bilayer (Pyburn et al., 2016). 
However, despite efforts to investigate the pore-forming domain of VacA, high 
resolution structural information is still unavailable. 
 Previous reports have indicated that the toxin has a strong preference for 
lipid raft lipids (Geisse et al., 2004; Gupta et al., 2008; Gupta et al., 2010; Kuo and 
Wang, 2003; Nakayama et al., 2006; Patel et al., 2002). Chapter III reports that 
VacA binds to multiple sets of lipid compositions which has been previously 
demonstrated using planar lipid bilayers experiments with atomic force microscopy 
(Geisse et al., 2004; Pyburn et al., 2016). The AFM study also showed that even 
when raft lipids sphingomyelin and cholesterol are present, VacA preferentially 
binds negatively charged phospholipids, namely phosphatidylserine (PS) (Geisse 
et al., 2004). In agreement with this data, Fig. 3-2A shows a significant difference 
in binding when PS is present. Interestingly, binding was also elevated in the 
presence of cholesterol despite previous reports suggesting VacA does not directly 
interact with cholesterol (Patel et al., 2002). Surprisingly, the presence of 
sphingomyelin alone in the absence of cholesterol, exhibited the least binding. 
One potential explanation for the differences in binding is the use of artificial 
membranes versus biological membranes. Biological membranes may have a lipid 
dispersion more suited to VacA targeting and binding lipid raft domains. 
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 VacA s2/i1/m1 showed a similar binding profile to s1/i1/m1 to lipid 
compositions tested in Chapter III (Fig. 3-10A) and inserted into the membrane 
according to sodium carbonate extraction experiments (Fig. 3-10B). The data 
suggest that membrane binding and insertion may not result in the reduced 
virulence exhibited by this variant. It may be possible that the 12 amino acid 
extension causes an altered pore to be formed, leading to reduced channel 
activity. Another possibility is that the intermediate and middle regions play a larger 
role in membrane binding and insertion and therefore variants with the i1 and m2 
should be investigated.  
 Data in Chapter III strongly suggests that VacA binds to membrane as a 
monomer, inserts into membrane and oligomerizes followed by pore formation 
(Fig. 5-1A). This mode of pore formation is similar to that of FraC and the 
proposed model for colicin A, both of which are a-PFTs. Both models suggest a 
hypothetical pre-pore intermediate where the oligomer is bound on the membrane 
surface but has not yet inserted. A high-resolution structure of VacA bound to and 
inserted into the liposomes could verify whether a pore has formed or if an 
intermediate structure where part of the toxin is inserted has been created. 
Future Directions 
  Investigating VacA oligomerization. The efforts toward a high-resolution 
structure of a soluble VacA oligomer are ongoing. Currently, the structure of 
residues 355-811 have been showed to compose a beta helix with a globular 
domain at the C-terminus. However, the remainder of the p55 domain has not 
been mapped and a structure of the pore-forming p33 domain has not been 
determined (Gangwer et al., 2007; Gonzalez-Rivera et al., 2016). How 
oligomerization into single-layer oligomers occurs and how double-layer formation 
occurs remain unknown and high-resolution structural analysis can begin to 
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answer these questions. Currently, cryo-EM analysis is being performed. As 
mentioned in Chapter IV, 3D classification is currently being revisited without 
applying symmetry. Another step to be taken is processing the dataset using 
different programs that are available for cryo-EM. Currently, RELION 1.4 is being 
utilized to classify and refine the data. A good technique during structure 
determination is to compare outputs from multiple programs. Both FREALIGN and 
SPARX (part of the newly developed SPHIRE) are software packages that should 
be explored for structure determination as each software package uses different 
algorithms (Grigorieff, 2007, 2016; Hohn et al., 2007). Recently, a newer version of 
RELION, RELION 2.0, has also been released. These differences could be critical 
when attempting to determine the highest resolution structure.  
 Investigating the VacA pore. The work presented in Chapter III has set the 
stage for determining a high-resolution structure of membrane inserted VacA. Lipid 
conditions have been determined that not only promote VacA insertion into 
membrane but has been previously been shown to promote active channel 
formation (Fig. 5-1A-D) (Czajkowsky et al., 1999; Iwamoto et al., 1999). 
Unfortunately, VacA inserted into LUVs would make structure determination by 
cryo-EM difficult. Negative stain analysis shows that VacA particles on LUVs are 
frequently close together and may be difficult to identify for selection as particles 
for classification (Fig. 5-2A-D). Three main methods of determining high resolution 
structures of membrane proteins today via cryo-EM are detergent micelles, 
amphipols and nanodiscs (Bokori-Brown et al., 2016; Gatsogiannis et al., 2016; 
Huynh et al., 2014). 
 Nanodisc technology utilizes a membrane scaffold protein (MSP) to act as 
a ‘belt’ around a lipid bilayer (Schuler et al., 2013). These discs range in size from 
13-17 nm in diameter, depending on the MSP truncation. Inconsistent disc sizes of 
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nanodiscs can occur which would negatively affect data processing, making it 
more difficult. Also, initial experiments suggest that the diameter is too small to fit a 
VacA hexamer which has a diameter of ~29 Å. Recently, larger nanodiscs have 
been created with diameters reaching 30 and 50 nm which are more consistent in 
size when prepared (Nasr et al., 2017). These nanodiscs should be prepared and 
tested for VacA binding. If VacA still does not bind to the nanodiscs well, the use of 
detergent micelles or amphipols should be explored to determine the structure of a 
VacA pore. First, VacA can be prepared as described using LUVs and then 
dialyzed against multiple detergents at different temperatures to determine optimal 
conditions. Similarly, different amphipols should be tested with VacA for optimal 
conditions (Fig. 5-2M-N).  
It is possible that the two aforementioned methods do not work due to 
difficulties with acid activation of VacA in the presence of detergent. Also, when 
VacA is bound to LUVs there can be unbound double-layer oligomers as well as 
soluble hexamers present which can make particle selection and classification in 
cryo-EM difficult (Fig. 5-2A-D). Therefore, progress has been made using VacA 
bound to small unilamellar vesicles (SUVs) (Fig. 5-2G-H). It was found that using 
the same lipid conditions used with LUV experiments, only preparing vesicles with 
a diameter of ~50 nm, that one VacA hexamer bound per SUV. This may the most 
promising method and recently there have been great strides in computational 
methods to handle the difficulties that arise from membrane curvature (Jensen et 
al., 2016a; Jensen et al., 2016b; Wang and Sigworth, 2009, 2010). Great care will 
need to be taken, with any of these methods, to isolate membrane bound VacA 
from unbound VacA, such as size exclusion chromatography, or a large dataset 
will need to be taken by cryo-EM since it may be difficult to differentiate VacA  
  112 
 
 
 
Figure 5-2. Efforts toward determining a high resolution structure of VacA 
bound to lipid. A) Negative stain image of LUVs comprised of ePC, DOPS, and 
cholesterol (55/15/30 mol%) in 10 mM HEPES pH 7.2 and 100 mM KCl. B) 
Negative stain image of VacA s1/i1/m1 bound to of ePC, DOPS, and cholesterol 
(55/15/30 mol%) LUVs at an LPR of 50:1. C) Image of ePC, DOPS, and 
cholesterol (55/15/30 mol%) LUVs in vitrified ice. D) Image of VacA s1/i1/m1 
bound to ePC, DOPS, and cholesterol (55/15/30 mol%) LUVs in vitrified ice. E) 
Negative stain image of a lipid nanotube composed of ePC, DOPS, cholesterol, 
and GalCer (7.5/15/27.5/50 mol%). F) Negative stain image of VacA s1/i1/m1 
bound to lipid nanotube. G) Negative stain image of ePC, DOPS, and cholesterol 
(55/15/30 mol%) SUVs. H) Negative stain image of Flag-tag VacA s1/i1/m1 bound 
to ePC, DOPS, and cholesterol (55/15/30 mol%) SUVs. I) Negative stain image of 
macrodiscs. J) Negative stain image of Flag-tag VacA s1/i1/m1 bound to 
macrodiscs. K) Negative stain image of 2D crystal of VacA s1/i1/m1. L) Negative 
stain image of 2D crystal of VacA s1/i1/m1. M) Negative stain image of neutral 
VacA s1/i1/m1 in A8-35. N) Negative stain image of acidified VacA s1/i1/m1 in A8-
35. 
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bound liposomes (liposomes containing only a few VacA particles) from empty 
liposomes in vitrified ice. Also, if in the presence of detergent micelles or 
amphipols, it may be difficult to differentiate between soluble hexamers and 
hexamers in a pore formed state.  
It is already known that VacA forms an anion channel, with a preference for 
choride ions (Adrian et al., 2002; Czajkowsky et al., 2005; Geisse et al., 2004; 
Tombola et al., 1999a). It has been demonstrated that when applied to LUVs, 
VacA s1/i1/m1, s2/i1/m1, and D6-27 are inserted into the membrane (Pyburn et al., 
2016). Unfortunately, while the assay shows VacA was inserted, the technique 
limited the ability to determine if an active pore had formed. Therefore, a 
biochemical assay using a fluorescent chloride ion indicator, such as calcein, in 
conjunction with the LUV composition utilized in Chapter III could be applied to 
determine if each VacA mutant/variant has created a functional pore under these 
conditions. High resolution structural analysis would greatly complement these 
studies. 
Computational modeling of the VacA pore suggested that Lys-33 was 
responsible for the anionic selectivity. In order to determine if this residue is 
responsible, mutating the residue to an alanine and performing planar lipid bilayer 
experiments could determine if the selectivity has been diminished. If anion 
selectivity has been altered with the mutation, this mutant should be applied to 
cells and tested for changes in cellular effects. The mutant should also be 
visualized by negative stain to assess if there are any differences in overall 
oligomer structure. 
 Understanding s2/i2/m2 virulence. In order to better understand why VacA 
s2/i1/m1 vacuolates cells less efficiently and why the s2/i2/m2 containing strain is 
less virulent than s1/i1/m1, high resolution structure determination of both soluble 
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and pore formed state of VacA s2/i1/m1 will be crucial to understand the 
differences. Potential explanations for the differences are 1) does s2/i1/m1 form 
incomplete pores due to the 12 amino acid hydrophilic extension at the N-
terminus? 2) is s2/i2/m2 trafficked differently leading to the slow progression of 
vacuolation? 3) are there fewer receptors found on gastric epithelial cells that will 
bind to s2/i2/m2? It would be interesting to test lipid binding and insertion using the 
i2 and m2 forms of VacA to see if there are differences when compared to their i1 
and m1 counterparts. Results of the aforementioned biochemical analysis could 
support the hypothesis that the s2/i1/m1 variant vacuolates less efficiently due to 
the formation of an altered pore. There are current studies investigating VacA 
trafficking using both VacA s1/i1/m1 and s2/i1/m1. Since the intermediate region 
has been proposed to be a major determinant of VacA virulence and the middle 
region is involved in receptor specificity, chimeras should be created to identify 
differences in intoxication and trafficking (Gonzalez-Rivera et al., 2012; Pagliaccia 
et al., 1998; Rhead et al., 2007). Results would aid in better understanding of 
VacA virulence. 
 VacA as a drug target. Lastly, since VacA is present in all strains of H. 
pylori, it would be beneficial to target this toxin to prevent its cellular effects. Pore-
forming toxins have recently become targets to develop therapeutics. For example, 
oroxylin A inhibits hemolytic acitivity of haemolysin A (Dong et al., 2013). DNA 
aptamers have been utilized in order to inhibit the action of a-toxin, and thus used 
to treat S. aureus infection (Vivekananda et al., 2014). Inhibitors of 
glycosylphosphatidylinositols (GPIs) have been suggested as targets to inhibit 
pore-formation by aerolysins (Wu and Guo, 2010). Chloride channels have also 
been targeted for drug development. For example, a well known chloride channel, 
the cystic fibrosis transmembrane conductance regulator (CFTR), was subjected 
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to small molecule screening which revealed two types of potential inhibitors 
(Verkman and Galietta, 2009). One inhibitor blocks channel function by 
interactions with a key residue at one end of the pore (Taddei et al., 2004). 
Potentially, this idea could be applied to Lys-33 of VacA. If mutational analysis of 
this residue reveals altered channel activity, small molecule screening could be 
performed to identify potential channel blockers. 
Once high resolution structures have been determined, potential inhibitors 
of pore-formation or oligomerization can begin to be investigated for therapeutics. 
Due to the increasing antibiotic resistance, developing a drug that would target this 
pore-forming toxin specifically would be essential in eradicating the infection.  
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APPENDIX 
 
Materials and Methods 
 
Preparation of nanotubes. The protocol for preparation of lipid nanotubes 
was modified from Wilson-Kubalek, et.al. 1998, 2000 (Dang et al., 2005a; Dang et 
al., 2005b; Wilson-Kubalek, 2000; Wilson-Kubalek et al., 1998). D-galactosyl-ß-1,1' 
N-nervonoyl-D-erythro-sphingosine (GalCer; Avanti Polar Lipids, Alabaster, AL) 
was rehydrated to a concentration of 5 mg/mL. Three lipid compositions were 
tested: DOPS/GalCer (50/50, 40/60, 30/70, 20/80, and 10/90 mol%), 
DOPS/GalCer/chol (30/55/15 and 20/70/10 mol%), and ePC/DOPS/chol/GalCer 
(27.5/7.5/15/50 mol%). Lipids were rehydrated in 10 mM HEPES pH 7.2, 100 mM 
KCl for one hour at RT. The lipid mixture was then sonicated for 3 to 6 minutes in a 
water bath. Nanotube formation was assessed by negative stain EM. Once 
nanotube formation was verified, acid activated VacA s1/i1/m1 was added to 
nanotubes (LPR range from 10:1 to 100:1) at RT and incubated for fifteen minutes 
and binding visualized by negative stain EM (Fig. 5-2E-F).  
Small Unilamellar Vesicles. Protocol adapted from the Morrisey lab 
protocol for preparation of SUVs. Lipid compositions used were 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC) and 1,2-dioleoyl-sn-glycero-3-phospho-L-serine 
(DOPS) (DOPC:DOPS 20/80 % of total moles (mol%)) and L-α-
phosphatidylcholine from egg (ePC), DOPS, and ovine cholesterol (55/15/30 
mol%). All lipids were purchased from Avanti Polar Lipids (Alabaster, AL). Briefly, 
lipids in chloroform (CHCl3) were mixed at the desired ratios and evaporated under 
a nitrogen stream, further dried in a vacuum for one hour, and rehydrated for one 
hour at room temperature (RT) in 10 mM HEPES pH 7.2 and 100 mM potassium 
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chloride (KCl) to a final concentration of 1 mg/mL lipid. The lipids were vigorously 
vortexed for one minute, then sonicated between 25-50 minutes in a water bath.  
 To first assess binding of VacA s1/i1/m1, VacA was acid activated to 
induce oligomer dissociation into monomers. Once acid activated, VacA and the 
SUVs were mixed at 37°C for fifteen minutes and then negative stain grids were 
prepared as described. Lipid-to-protein ratios (LPRs; weight to weight) used 
ranged from 25:1 to 50:1, LUVs to protein. 
 Once it was determined that VacA binds to SUVs, Flag tag VacA s1/i1/m1 
was utilized to separate unbound from bound SUVs. Once VacA bound SUVs 
were prepared, sample was added to 250 µL Anti-Flag M2 Affinity Gel (Sigma-
Aldrich) and nutated for one hour at RT. After washing with 12 column volumes 
(CVs) of HEPES Buffered Saline (HBS), 18 µL of 3x Flag peptide (Sigma-Aldrich) 
was added. The mixture was nutated for 30 minutes at RT and purified sample 
eluted (Fig. 5-2G-H).  
 Preparation of macrodiscs. The protocol for the preparation of macrodiscs 
was modified from Park, et.al. (Park et al., 2011). The peptide used for macrosdisc 
formation, Ac-DYLKAFYDKLKEAF-NH2, was purchased from BioSynthesis and 
rehydrated in 10mM HEPES pH 7.2 and 100 mM KCl. Lipids (DMPC and 
ePC/DOPS/cholesterol 55/15/30 mol%) were dried under a nitrogen stream and 
further dried in a vacuum for 18 hours. Lipids were rehydrated in buffer containing 
the peptide at a 13.3 mol ratio (lipid:peptide) and vortexed. Next, the lipid/peptide 
mixture was warmed and cooled for six cycles using an ice bath and 37°C water 
bath. Macrodisc formation was assessed using negative stain EM. Acidified Flag-
tag VacA s1/i1/m1 was added to macrodiscs at neutral pH to assess binding. 
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Separation of empty macrodiscs and macrodiscs with bound VacA was performed 
as previously described for SUVs (Fig. 5-2I-J).   
 Preparation of 2D crystals. This protocol was adapted from several 
sources. (Abeyrathne et al., 2010; Hasler et al., 1998). Total heart extract lipids 
(Avanti Polar Lipids) were dried under a nitrogen gas stream and further dried in a 
vacuum. Lipids were then solubilized in detergent (3-[(3-
Cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate, CHAPS; n-Octyl-
β-D-Glucopyranoside, OG; n-Decyl-α-D-Maltopyranoside, DM). Acid activated 
VacA was added to the detergent solubilized lipids (LPRs ranging from 1:1 to 1:20) 
to a final volume of 60 µL and then placed in 50 µL dialysis buttons (Hampton 
Research) and 20,000 MWCO dialysis tubing (Spectrum Labs) placed over it. The 
buttons were then placed in dialysis buffers (listed below) and placed at either RT 
or 4°C and mixed for 3 to 5 days. Buttons were then removed and negative stain 
grids prepared of samples (Fig. 5-2K-L).  
Dialysis buffers:  
10 mM glycine pH 3.5, 100 mM KCl, 2 mM MgCl2 
10 mM sodium citrate pH 5, 100 mM KCl 
10 mM HEPES pH 7.2, 100 mM KCl 
30 mM HEPES pH 7.2, 70 mM KCl 
 Amphipol preparation. Prepared 10% A8-35 amphipol in 10 mM HEPES pH 
7.2 and 100 mM KCl. Mixed A8-35 with neutral and acidified VacA s1/i1/m1 and 
VacA D346-347 at three different ratios, 1:1, 1:2, 1:3, and 1:4 (amphipol:protein 
w/w). Samples were visualized with negative stain EM (Fig. 5-2M-N). 
 
